| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 503 | 2025 | 6291 | 23.120 |
Why?
|
| Vitamin D | 79 | 2024 | 3311 | 7.360 |
Why?
|
| Anti-Asthmatic Agents | 49 | 2024 | 577 | 5.100 |
Why?
|
| Respiratory Sounds | 58 | 2024 | 702 | 4.880 |
Why?
|
| Forced Expiratory Volume | 151 | 2025 | 1831 | 4.440 |
Why?
|
| Pharmacogenetics | 33 | 2016 | 683 | 3.770 |
Why?
|
| Polymorphism, Single Nucleotide | 154 | 2024 | 16045 | 3.680 |
Why?
|
| Genome-Wide Association Study | 102 | 2024 | 12795 | 3.470 |
Why?
|
| Adrenal Cortex Hormones | 44 | 2024 | 1886 | 3.150 |
Why?
|
| Bronchodilator Agents | 42 | 2024 | 518 | 3.130 |
Why?
|
| Bronchial Hyperreactivity | 45 | 2017 | 301 | 3.010 |
Why?
|
| Hypersensitivity | 44 | 2024 | 1172 | 2.980 |
Why?
|
| Lung | 111 | 2024 | 10099 | 2.960 |
Why?
|
| Hypersensitivity, Immediate | 33 | 2023 | 349 | 2.870 |
Why?
|
| Pre-Eclampsia | 10 | 2023 | 1255 | 2.700 |
Why?
|
| Vitamin D Deficiency | 25 | 2024 | 1388 | 2.630 |
Why?
|
| Vitamins | 22 | 2024 | 1638 | 2.580 |
Why?
|
| Respiratory Function Tests | 64 | 2024 | 1695 | 2.400 |
Why?
|
| Immunoglobulin E | 63 | 2024 | 1506 | 2.360 |
Why?
|
| Genetic Predisposition to Disease | 111 | 2024 | 18065 | 2.290 |
Why?
|
| Vital Capacity | 68 | 2025 | 996 | 2.180 |
Why?
|
| Bronchi | 36 | 2024 | 850 | 2.120 |
Why?
|
| Lung Diseases, Obstructive | 38 | 2001 | 311 | 2.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 37 | 2025 | 3252 | 2.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 24 | 2024 | 2538 | 1.850 |
Why?
|
| Methacholine Chloride | 38 | 2017 | 220 | 1.840 |
Why?
|
| Polymorphism, Genetic | 41 | 2016 | 4249 | 1.830 |
Why?
|
| Humans | 1018 | 2025 | 768166 | 1.780 |
Why?
|
| MicroRNAs | 21 | 2025 | 3803 | 1.770 |
Why?
|
| Dietary Supplements | 23 | 2024 | 3445 | 1.760 |
Why?
|
| Phenotype | 98 | 2024 | 16726 | 1.760 |
Why?
|
| Adrenergic beta-Agonists | 23 | 2014 | 347 | 1.740 |
Why?
|
| Child | 316 | 2025 | 80917 | 1.710 |
Why?
|
| Smoking | 132 | 2024 | 9092 | 1.650 |
Why?
|
| Allergens | 50 | 2024 | 1443 | 1.630 |
Why?
|
| Receptors, Adrenergic, beta-2 | 20 | 2015 | 216 | 1.620 |
Why?
|
| Intracranial Aneurysm | 19 | 2024 | 1271 | 1.610 |
Why?
|
| Genotype | 89 | 2024 | 13045 | 1.580 |
Why?
|
| Pregnancy | 106 | 2024 | 30256 | 1.570 |
Why?
|
| Aneurysm, Ruptured | 14 | 2021 | 455 | 1.570 |
Why?
|
| Female | 596 | 2025 | 397192 | 1.550 |
Why?
|
| Eczema | 15 | 2022 | 245 | 1.530 |
Why?
|
| Bronchial Provocation Tests | 51 | 2016 | 216 | 1.530 |
Why?
|
| Genome, Human | 31 | 2024 | 4446 | 1.490 |
Why?
|
| Male | 629 | 2025 | 364719 | 1.480 |
Why?
|
| Cholecalciferol | 7 | 2024 | 557 | 1.460 |
Why?
|
| Child, Preschool | 169 | 2024 | 42669 | 1.450 |
Why?
|
| Linkage Disequilibrium | 36 | 2021 | 1997 | 1.440 |
Why?
|
| Gene Expression Profiling | 29 | 2024 | 9538 | 1.430 |
Why?
|
| Budesonide | 22 | 2020 | 162 | 1.420 |
Why?
|
| Aging | 75 | 2021 | 8744 | 1.400 |
Why?
|
| Administration, Inhalation | 46 | 2024 | 1169 | 1.360 |
Why?
|
| Skin Tests | 46 | 2016 | 639 | 1.320 |
Why?
|
| Nedocromil | 17 | 2019 | 45 | 1.280 |
Why?
|
| Genetic Variation | 42 | 2024 | 6611 | 1.250 |
Why?
|
| Prenatal Care | 5 | 2020 | 1162 | 1.200 |
Why?
|
| Leukotriene Antagonists | 11 | 2015 | 124 | 1.160 |
Why?
|
| Respiratory Tract Diseases | 16 | 2016 | 744 | 1.150 |
Why?
|
| Premature Birth | 6 | 2023 | 1829 | 1.130 |
Why?
|
| Sphingolipids | 5 | 2023 | 178 | 1.130 |
Why?
|
| Anti-Inflammatory Agents | 22 | 2017 | 1805 | 1.090 |
Why?
|
| Haplotypes | 35 | 2024 | 2722 | 1.090 |
Why?
|
| Fetal Blood | 15 | 2023 | 1361 | 1.070 |
Why?
|
| Genetic Linkage | 21 | 2008 | 2342 | 1.040 |
Why?
|
| Epithelial Cells | 10 | 2024 | 3703 | 1.040 |
Why?
|
| Gene Frequency | 38 | 2024 | 3623 | 1.040 |
Why?
|
| Adult | 383 | 2025 | 223646 | 1.040 |
Why?
|
| Hygiene | 5 | 2015 | 95 | 1.030 |
Why?
|
| Tobacco Smoke Pollution | 25 | 2011 | 828 | 0.990 |
Why?
|
| Dermatitis, Atopic | 11 | 2024 | 737 | 0.980 |
Why?
|
| Spirometry | 43 | 2024 | 929 | 0.980 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 5 | 2009 | 88 | 0.960 |
Why?
|
| Metabolomics | 14 | 2024 | 1674 | 0.940 |
Why?
|
| Genomics | 22 | 2024 | 5926 | 0.930 |
Why?
|
| Gene Regulatory Networks | 16 | 2024 | 1752 | 0.910 |
Why?
|
| Bronchoconstrictor Agents | 14 | 2016 | 77 | 0.900 |
Why?
|
| Lead | 22 | 2021 | 882 | 0.890 |
Why?
|
| Airway Resistance | 6 | 2020 | 407 | 0.870 |
Why?
|
| Respiratory Hypersensitivity | 16 | 2023 | 272 | 0.870 |
Why?
|
| DNA Methylation | 18 | 2024 | 4428 | 0.870 |
Why?
|
| Environmental Exposure | 36 | 2024 | 4543 | 0.840 |
Why?
|
| Eosinophils | 21 | 2023 | 952 | 0.830 |
Why?
|
| Metalloendopeptidases | 5 | 2004 | 386 | 0.830 |
Why?
|
| Software | 18 | 2024 | 4478 | 0.820 |
Why?
|
| Pyroglyphidae | 5 | 2024 | 92 | 0.820 |
Why?
|
| Adolescent | 197 | 2025 | 89169 | 0.820 |
Why?
|
| Cross-Cultural Comparison | 9 | 2000 | 638 | 0.800 |
Why?
|
| Food Hypersensitivity | 5 | 2024 | 734 | 0.800 |
Why?
|
| Respiratory System | 5 | 2018 | 564 | 0.790 |
Why?
|
| Interleukin-13 | 9 | 2011 | 390 | 0.780 |
Why?
|
| Developmental Disabilities | 3 | 2020 | 1518 | 0.780 |
Why?
|
| Costa Rica | 21 | 2025 | 186 | 0.780 |
Why?
|
| Case-Control Studies | 66 | 2024 | 22291 | 0.770 |
Why?
|
| Computational Biology | 12 | 2020 | 3568 | 0.760 |
Why?
|
| Cohort Studies | 115 | 2024 | 41754 | 0.730 |
Why?
|
| Middle Aged | 293 | 2025 | 223492 | 0.730 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2022 | 587 | 0.720 |
Why?
|
| Lung Diseases | 15 | 2018 | 1944 | 0.720 |
Why?
|
| Chromosome Mapping | 21 | 2018 | 4620 | 0.720 |
Why?
|
| Eosinophilia | 11 | 2020 | 556 | 0.720 |
Why?
|
| Gene Expression Regulation | 30 | 2024 | 11928 | 0.710 |
Why?
|
| Albuterol | 17 | 2018 | 211 | 0.700 |
Why?
|
| Risk Factors | 141 | 2024 | 74944 | 0.690 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 7 | 2024 | 110 | 0.690 |
Why?
|
| Leukocyte Count | 24 | 2018 | 1609 | 0.690 |
Why?
|
| Alcohol Drinking | 23 | 2022 | 4045 | 0.680 |
Why?
|
| Chromosomes, Human, Pair 12 | 5 | 2011 | 432 | 0.680 |
Why?
|
| Longitudinal Studies | 97 | 2017 | 14783 | 0.680 |
Why?
|
| Pregnancy Trimester, First | 7 | 2022 | 917 | 0.670 |
Why?
|
| Double-Blind Method | 40 | 2022 | 12465 | 0.670 |
Why?
|
| Genetic Loci | 14 | 2023 | 2629 | 0.660 |
Why?
|
| Genetics, Population | 8 | 2024 | 944 | 0.650 |
Why?
|
| Systems Biology | 4 | 2018 | 482 | 0.650 |
Why?
|
| Respiratory Mechanics | 11 | 2015 | 721 | 0.640 |
Why?
|
| Receptors, IgE | 3 | 2011 | 375 | 0.640 |
Why?
|
| Muscle, Smooth | 6 | 2015 | 931 | 0.640 |
Why?
|
| Genome | 5 | 2024 | 1754 | 0.630 |
Why?
|
| Infant, Newborn | 53 | 2024 | 26422 | 0.630 |
Why?
|
| Stress, Mechanical | 3 | 2022 | 1676 | 0.630 |
Why?
|
| Pregnancy Complications | 8 | 2023 | 2973 | 0.630 |
Why?
|
| Airway Remodeling | 1 | 2020 | 133 | 0.620 |
Why?
|
| Bayes Theorem | 11 | 2022 | 2359 | 0.610 |
Why?
|
| Infant | 77 | 2024 | 36535 | 0.610 |
Why?
|
| Alleles | 29 | 2021 | 6894 | 0.600 |
Why?
|
| Metabolome | 9 | 2024 | 1009 | 0.600 |
Why?
|
| Disease | 2 | 2021 | 675 | 0.600 |
Why?
|
| Jews | 8 | 1999 | 359 | 0.600 |
Why?
|
| Quantitative Trait Loci | 15 | 2022 | 2131 | 0.600 |
Why?
|
| Body Mass Index | 43 | 2024 | 13053 | 0.590 |
Why?
|
| Autoimmune Diseases | 5 | 2014 | 2257 | 0.590 |
Why?
|
| Bronchoconstriction | 8 | 2016 | 141 | 0.580 |
Why?
|
| Receptors, Glucocorticoid | 4 | 2017 | 309 | 0.580 |
Why?
|
| Chromosomes, Human, Pair 17 | 4 | 2019 | 418 | 0.580 |
Why?
|
| Subarachnoid Hemorrhage | 6 | 2024 | 1024 | 0.570 |
Why?
|
| Maternal Exposure | 10 | 2024 | 1096 | 0.570 |
Why?
|
| Receptors, Cell Surface | 9 | 2009 | 2819 | 0.570 |
Why?
|
| Aged | 207 | 2024 | 171504 | 0.560 |
Why?
|
| Gene Expression | 12 | 2020 | 7598 | 0.560 |
Why?
|
| Algorithms | 32 | 2024 | 14164 | 0.560 |
Why?
|
| Obesity | 32 | 2023 | 13090 | 0.560 |
Why?
|
| Infant, Premature | 7 | 2020 | 2124 | 0.560 |
Why?
|
| Cathelicidins | 1 | 2017 | 81 | 0.560 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2023 | 1049 | 0.560 |
Why?
|
| Antigens, Dermatophagoides | 13 | 2024 | 101 | 0.550 |
Why?
|
| Feces | 8 | 2022 | 1511 | 0.550 |
Why?
|
| Models, Genetic | 26 | 2022 | 3447 | 0.540 |
Why?
|
| Regression Analysis | 50 | 2013 | 6340 | 0.540 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 718 | 0.540 |
Why?
|
| Linear Models | 31 | 2024 | 5884 | 0.540 |
Why?
|
| Proteins | 10 | 2020 | 6009 | 0.540 |
Why?
|
| Religion and Psychology | 6 | 1995 | 180 | 0.530 |
Why?
|
| Pneumonia | 5 | 2024 | 2163 | 0.530 |
Why?
|
| Dust | 6 | 2015 | 488 | 0.530 |
Why?
|
| Genetic Testing | 17 | 2022 | 3591 | 0.520 |
Why?
|
| T-Box Domain Proteins | 4 | 2019 | 472 | 0.520 |
Why?
|
| Bacteria | 8 | 2020 | 2216 | 0.510 |
Why?
|
| Epigenesis, Genetic | 10 | 2023 | 3833 | 0.510 |
Why?
|
| Severity of Illness Index | 49 | 2024 | 15948 | 0.510 |
Why?
|
| Islam | 7 | 1997 | 72 | 0.510 |
Why?
|
| Membrane Proteins | 11 | 2019 | 7876 | 0.510 |
Why?
|
| Cytokines | 17 | 2023 | 7453 | 0.500 |
Why?
|
| Prospective Studies | 83 | 2024 | 54926 | 0.500 |
Why?
|
| Steroids | 11 | 2021 | 938 | 0.500 |
Why?
|
| Models, Biological | 15 | 2016 | 9495 | 0.490 |
Why?
|
| Diet | 22 | 2025 | 8089 | 0.490 |
Why?
|
| Pedigree | 19 | 2020 | 4539 | 0.490 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 133 | 0.490 |
Why?
|
| Neoplasm Proteins | 8 | 2024 | 3603 | 0.480 |
Why?
|
| Animals | 115 | 2024 | 169246 | 0.470 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 4 | 2023 | 88 | 0.470 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2023 | 1399 | 0.470 |
Why?
|
| Leukocytes, Mononuclear | 11 | 2020 | 1854 | 0.470 |
Why?
|
| Genetic Association Studies | 13 | 2021 | 2744 | 0.470 |
Why?
|
| Hydroxyurea | 3 | 2018 | 284 | 0.470 |
Why?
|
| Glucocorticoids | 10 | 2017 | 2167 | 0.470 |
Why?
|
| Health Surveys | 12 | 2009 | 4057 | 0.460 |
Why?
|
| Nuclear Family | 8 | 2008 | 311 | 0.460 |
Why?
|
| Genes, Developmental | 1 | 2014 | 38 | 0.460 |
Why?
|
| Coronary Disease | 15 | 2002 | 5919 | 0.460 |
Why?
|
| Hostility | 4 | 2006 | 185 | 0.450 |
Why?
|
| Area Under Curve | 7 | 2024 | 1643 | 0.440 |
Why?
|
| Sarcoma, Experimental | 1 | 2013 | 117 | 0.440 |
Why?
|
| MMPI | 4 | 2003 | 81 | 0.440 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2013 | 58 | 0.440 |
Why?
|
| Sex Characteristics | 11 | 2016 | 2650 | 0.440 |
Why?
|
| Aged, 80 and over | 85 | 2024 | 59629 | 0.440 |
Why?
|
| Air Pollution, Indoor | 11 | 2020 | 931 | 0.440 |
Why?
|
| Salmonidae | 2 | 2003 | 13 | 0.430 |
Why?
|
| Interleukin-10 | 8 | 2009 | 1183 | 0.430 |
Why?
|
| Mothers | 11 | 2023 | 2209 | 0.430 |
Why?
|
| Biological Specimen Banks | 5 | 2021 | 788 | 0.430 |
Why?
|
| Respiratory Insufficiency | 4 | 2022 | 1240 | 0.430 |
Why?
|
| Integrin beta Chains | 1 | 2013 | 115 | 0.430 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2013 | 39 | 0.420 |
Why?
|
| Endophenotypes | 1 | 2015 | 259 | 0.420 |
Why?
|
| Respiration | 9 | 2008 | 1665 | 0.420 |
Why?
|
| Fetus | 4 | 2023 | 1883 | 0.420 |
Why?
|
| Rhinovirus | 4 | 2018 | 209 | 0.420 |
Why?
|
| Randomized Controlled Trials as Topic | 16 | 2022 | 10399 | 0.410 |
Why?
|
| Age Factors | 57 | 2021 | 18412 | 0.410 |
Why?
|
| Cross-Sectional Studies | 67 | 2024 | 26379 | 0.410 |
Why?
|
| NFATC Transcription Factors | 3 | 2020 | 393 | 0.410 |
Why?
|
| Neoplasms, Experimental | 2 | 2015 | 1230 | 0.410 |
Why?
|
| Receptors, Calcitriol | 5 | 2024 | 361 | 0.410 |
Why?
|
| Logistic Models | 42 | 2024 | 13290 | 0.400 |
Why?
|
| Genetic Markers | 22 | 2015 | 2603 | 0.400 |
Why?
|
| Quantitative Trait, Heritable | 10 | 2008 | 540 | 0.400 |
Why?
|
| Models, Statistical | 16 | 2021 | 5107 | 0.400 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2013 | 165 | 0.400 |
Why?
|
| Family | 20 | 2024 | 3209 | 0.400 |
Why?
|
| Incidence | 29 | 2020 | 21538 | 0.400 |
Why?
|
| Aspirin | 4 | 2020 | 3135 | 0.390 |
Why?
|
| Gestational Age | 12 | 2023 | 3621 | 0.390 |
Why?
|
| Blood Pressure | 26 | 2014 | 8543 | 0.390 |
Why?
|
| Salmonella typhimurium | 1 | 2014 | 348 | 0.390 |
Why?
|
| Cyprinidae | 1 | 2011 | 35 | 0.390 |
Why?
|
| Th2 Cells | 6 | 2024 | 1078 | 0.390 |
Why?
|
| Rhinitis, Allergic, Seasonal | 7 | 2017 | 104 | 0.390 |
Why?
|
| Multivariate Analysis | 43 | 2020 | 12077 | 0.380 |
Why?
|
| Fibrosarcoma | 1 | 2013 | 313 | 0.380 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2011 | 792 | 0.380 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2016 | 3610 | 0.380 |
Why?
|
| Transcription, Genetic | 9 | 2021 | 7608 | 0.380 |
Why?
|
| Autophagy | 3 | 2017 | 1349 | 0.380 |
Why?
|
| Interferon-beta | 1 | 2013 | 349 | 0.380 |
Why?
|
| China | 19 | 2021 | 2395 | 0.380 |
Why?
|
| Long-Term Care | 1 | 2015 | 631 | 0.380 |
Why?
|
| Maximal Midexpiratory Flow Rate | 7 | 2004 | 75 | 0.380 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2012 | 117 | 0.370 |
Why?
|
| Air Pollutants | 6 | 2019 | 2916 | 0.370 |
Why?
|
| Databases, Genetic | 9 | 2021 | 1758 | 0.370 |
Why?
|
| Sequence Analysis, RNA | 9 | 2019 | 2040 | 0.370 |
Why?
|
| Interferon Regulatory Factors | 3 | 2019 | 271 | 0.370 |
Why?
|
| Odds Ratio | 27 | 2020 | 9669 | 0.370 |
Why?
|
| Host-Pathogen Interactions | 4 | 2017 | 1469 | 0.370 |
Why?
|
| Acetates | 3 | 2012 | 317 | 0.360 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 393 | 0.360 |
Why?
|
| Cell Line | 23 | 2024 | 15597 | 0.360 |
Why?
|
| Mexican Americans | 6 | 2022 | 165 | 0.360 |
Why?
|
| Inflammation | 16 | 2024 | 10873 | 0.360 |
Why?
|
| Anterior Cerebral Artery | 2 | 2021 | 50 | 0.360 |
Why?
|
| Young Adult | 42 | 2022 | 60066 | 0.360 |
Why?
|
| Metagenomics | 4 | 2023 | 474 | 0.360 |
Why?
|
| Respiratory Tract Infections | 14 | 2006 | 1014 | 0.360 |
Why?
|
| Gastrointestinal Tract | 2 | 2020 | 840 | 0.350 |
Why?
|
| Virus Diseases | 3 | 2015 | 724 | 0.350 |
Why?
|
| Principal Component Analysis | 7 | 2021 | 948 | 0.350 |
Why?
|
| Treatment Outcome | 53 | 2024 | 65371 | 0.350 |
Why?
|
| Epithelium | 3 | 2021 | 1607 | 0.350 |
Why?
|
| Respiration Disorders | 7 | 1997 | 364 | 0.350 |
Why?
|
| Cystic Fibrosis | 4 | 2009 | 1294 | 0.350 |
Why?
|
| Body Constitution | 8 | 2001 | 273 | 0.350 |
Why?
|
| Child Development | 3 | 2023 | 2330 | 0.350 |
Why?
|
| Research Design | 16 | 2015 | 6211 | 0.350 |
Why?
|
| Fetal Development | 5 | 2020 | 779 | 0.350 |
Why?
|
| Melanoma, Experimental | 1 | 2013 | 559 | 0.350 |
Why?
|
| Riluzole | 1 | 2010 | 62 | 0.350 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 2271 | 0.350 |
Why?
|
| Placenta | 6 | 2023 | 1725 | 0.350 |
Why?
|
| Mice | 51 | 2024 | 82029 | 0.340 |
Why?
|
| Christianity | 4 | 1995 | 53 | 0.340 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2010 | 350 | 0.340 |
Why?
|
| C-Reactive Protein | 8 | 2023 | 3858 | 0.340 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 6 | 2021 | 325 | 0.340 |
Why?
|
| Basilar Artery | 2 | 2021 | 207 | 0.340 |
Why?
|
| Biofilms | 1 | 2014 | 634 | 0.330 |
Why?
|
| Alcoholism | 9 | 1995 | 1980 | 0.330 |
Why?
|
| Membrane Glycoproteins | 7 | 2011 | 3711 | 0.330 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 2009 | 93 | 0.330 |
Why?
|
| RNA-Binding Proteins | 2 | 2020 | 1890 | 0.330 |
Why?
|
| Chondrogenesis | 2 | 2011 | 239 | 0.330 |
Why?
|
| Nurse-Patient Relations | 1 | 2009 | 101 | 0.330 |
Why?
|
| Body Height | 14 | 2024 | 1565 | 0.330 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 42 | 0.320 |
Why?
|
| Cluster Analysis | 9 | 2022 | 2732 | 0.320 |
Why?
|
| CpG Islands | 9 | 2024 | 1208 | 0.320 |
Why?
|
| Circle of Willis | 4 | 2023 | 77 | 0.320 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2024 | 365 | 0.320 |
Why?
|
| Medical Records Systems, Computerized | 4 | 2009 | 1196 | 0.320 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 75 | 0.320 |
Why?
|
| Multifactorial Inheritance | 4 | 2023 | 1422 | 0.320 |
Why?
|
| ROC Curve | 7 | 2020 | 3628 | 0.320 |
Why?
|
| Karyopherins | 1 | 2009 | 134 | 0.310 |
Why?
|
| Insulin | 12 | 2000 | 6607 | 0.310 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2014 | 1276 | 0.310 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2010 | 327 | 0.310 |
Why?
|
| Integrin beta3 | 1 | 2009 | 120 | 0.310 |
Why?
|
| Multiple Organ Failure | 2 | 2022 | 388 | 0.310 |
Why?
|
| Histamine | 13 | 2000 | 496 | 0.310 |
Why?
|
| Follow-Up Studies | 55 | 2020 | 39348 | 0.310 |
Why?
|
| Sodium Channels | 1 | 2010 | 341 | 0.310 |
Why?
|
| RNA, Messenger | 17 | 2023 | 12800 | 0.310 |
Why?
|
| Natural Language Processing | 5 | 2020 | 1203 | 0.310 |
Why?
|
| Fluocinolone Acetonide | 2 | 2009 | 38 | 0.300 |
Why?
|
| Immunoglobulins | 1 | 2011 | 855 | 0.300 |
Why?
|
| Israel | 16 | 1999 | 726 | 0.300 |
Why?
|
| Helminthiasis | 2 | 2000 | 81 | 0.300 |
Why?
|
| Sex Factors | 35 | 2016 | 10632 | 0.300 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3139 | 0.300 |
Why?
|
| Vitamin E Deficiency | 1 | 2008 | 30 | 0.300 |
Why?
|
| Arginase | 1 | 2008 | 81 | 0.300 |
Why?
|
| Reference Values | 22 | 2012 | 4938 | 0.300 |
Why?
|
| Body Weight | 9 | 2011 | 4627 | 0.300 |
Why?
|
| Predictive Value of Tests | 30 | 2024 | 15454 | 0.290 |
Why?
|
| Dexamethasone | 6 | 2018 | 1965 | 0.290 |
Why?
|
| Chromosome Inversion | 1 | 2008 | 119 | 0.290 |
Why?
|
| Risk | 32 | 2020 | 9613 | 0.290 |
Why?
|
| Drug Labeling | 1 | 2010 | 250 | 0.290 |
Why?
|
| Electronic Health Records | 7 | 2022 | 4887 | 0.290 |
Why?
|
| Neutrophils | 5 | 2014 | 3786 | 0.290 |
Why?
|
| Drug Resistance | 5 | 2019 | 1599 | 0.290 |
Why?
|
| Interleukin-1 | 2 | 2009 | 1252 | 0.290 |
Why?
|
| Picornaviridae Infections | 3 | 2017 | 96 | 0.280 |
Why?
|
| Insulin Resistance | 6 | 1998 | 3986 | 0.280 |
Why?
|
| Haploidy | 1 | 2007 | 127 | 0.280 |
Why?
|
| Anti-Bacterial Agents | 6 | 2014 | 7477 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 16 | 2017 | 5797 | 0.280 |
Why?
|
| Alcohol-Related Disorders | 2 | 2000 | 243 | 0.280 |
Why?
|
| Recurrence | 17 | 2020 | 8509 | 0.280 |
Why?
|
| Inservice Training | 1 | 2009 | 375 | 0.280 |
Why?
|
| Chemokines, CC | 2 | 2006 | 286 | 0.280 |
Why?
|
| Fatty Acids | 6 | 2023 | 1812 | 0.280 |
Why?
|
| Methacholine Compounds | 5 | 1990 | 35 | 0.280 |
Why?
|
| Quinolines | 3 | 2012 | 772 | 0.270 |
Why?
|
| Data Interpretation, Statistical | 11 | 2019 | 2709 | 0.270 |
Why?
|
| Attitude to Health | 3 | 2009 | 2025 | 0.270 |
Why?
|
| Base Sequence | 16 | 2023 | 12421 | 0.270 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2010 | 483 | 0.270 |
Why?
|
| Capnography | 2 | 2024 | 90 | 0.270 |
Why?
|
| Analysis of Variance | 20 | 2015 | 6229 | 0.270 |
Why?
|
| Boston | 32 | 2016 | 9374 | 0.270 |
Why?
|
| Family Health | 9 | 2006 | 1255 | 0.270 |
Why?
|
| Cell Adhesion Molecules | 3 | 2019 | 1613 | 0.270 |
Why?
|
| Placebos | 9 | 2017 | 1667 | 0.260 |
Why?
|
| Disease Susceptibility | 5 | 2019 | 1793 | 0.260 |
Why?
|
| Physician-Patient Relations | 3 | 2009 | 3269 | 0.260 |
Why?
|
| Endotoxins | 3 | 2004 | 519 | 0.260 |
Why?
|
| United States | 62 | 2023 | 73039 | 0.260 |
Why?
|
| Nose | 2 | 2020 | 522 | 0.260 |
Why?
|
| Clinical Trials as Topic | 12 | 2023 | 8054 | 0.260 |
Why?
|
| Clostridium Infections | 3 | 2023 | 562 | 0.260 |
Why?
|
| Germ-Line Mutation | 4 | 2023 | 1885 | 0.260 |
Why?
|
| Sepsis | 4 | 2022 | 2608 | 0.260 |
Why?
|
| Lectins, C-Type | 1 | 2009 | 594 | 0.260 |
Why?
|
| Forkhead Transcription Factors | 3 | 2020 | 1625 | 0.260 |
Why?
|
| Lod Score | 8 | 2006 | 600 | 0.260 |
Why?
|
| Managed Care Programs | 6 | 2005 | 939 | 0.250 |
Why?
|
| RNA, Bacterial | 2 | 2019 | 393 | 0.250 |
Why?
|
| Eicosanoids | 2 | 2024 | 284 | 0.250 |
Why?
|
| Fish Oils | 2 | 2019 | 483 | 0.250 |
Why?
|
| Sunlight | 1 | 2007 | 337 | 0.250 |
Why?
|
| Wnt Proteins | 1 | 2009 | 725 | 0.250 |
Why?
|
| Interferons | 3 | 2022 | 720 | 0.250 |
Why?
|
| Computer Simulation | 19 | 2023 | 6283 | 0.250 |
Why?
|
| Interleukin-9 | 2 | 2016 | 62 | 0.250 |
Why?
|
| Interleukin-8 | 3 | 2023 | 704 | 0.250 |
Why?
|
| Ascorbic Acid | 5 | 2005 | 658 | 0.250 |
Why?
|
| Temperance | 2 | 1995 | 88 | 0.250 |
Why?
|
| Chromosomes, Human | 3 | 2018 | 438 | 0.250 |
Why?
|
| Lymphotoxin-alpha | 1 | 2005 | 94 | 0.250 |
Why?
|
| Artificial Intelligence | 2 | 2011 | 2665 | 0.240 |
Why?
|
| Communication | 1 | 2019 | 3905 | 0.240 |
Why?
|
| Breast Feeding | 9 | 2018 | 1363 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2024 | 3800 | 0.240 |
Why?
|
| Epidemics | 1 | 2011 | 517 | 0.240 |
Why?
|
| beta-Defensins | 1 | 2005 | 60 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2022 | 1656 | 0.240 |
Why?
|
| Chondrocytes | 1 | 2010 | 800 | 0.240 |
Why?
|
| Reproducibility of Results | 18 | 2024 | 20227 | 0.240 |
Why?
|
| Cardiovascular Diseases | 16 | 2023 | 15662 | 0.240 |
Why?
|
| Quantum Dots | 2 | 2009 | 168 | 0.230 |
Why?
|
| Lead Poisoning | 6 | 2003 | 323 | 0.230 |
Why?
|
| Diet Records | 2 | 2024 | 426 | 0.230 |
Why?
|
| Cerebral Angiography | 5 | 2021 | 1264 | 0.230 |
Why?
|
| Microsatellite Repeats | 4 | 2011 | 785 | 0.230 |
Why?
|
| Interferon-gamma | 6 | 2006 | 3160 | 0.230 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 2726 | 0.230 |
Why?
|
| Cotinine | 5 | 2022 | 206 | 0.230 |
Why?
|
| Folic Acid | 4 | 2017 | 1337 | 0.230 |
Why?
|
| Dietary Fats | 4 | 2018 | 2003 | 0.230 |
Why?
|
| Sample Size | 6 | 2023 | 846 | 0.230 |
Why?
|
| Interleukin-12 Subunit p40 | 2 | 2019 | 59 | 0.230 |
Why?
|
| Multigene Family | 3 | 2005 | 1081 | 0.220 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2020 | 2885 | 0.220 |
Why?
|
| ADAM Proteins | 6 | 2007 | 242 | 0.220 |
Why?
|
| Models, Theoretical | 13 | 2020 | 3573 | 0.220 |
Why?
|
| Internet | 4 | 2014 | 3110 | 0.220 |
Why?
|
| Physical Examination | 2 | 2004 | 1263 | 0.220 |
Why?
|
| Middle Cerebral Artery | 2 | 2023 | 271 | 0.220 |
Why?
|
| Glucuronosyltransferase | 1 | 2024 | 136 | 0.220 |
Why?
|
| Caffeine | 2 | 2022 | 703 | 0.220 |
Why?
|
| Cell Physiological Phenomena | 1 | 2005 | 152 | 0.220 |
Why?
|
| Fibroblasts | 8 | 2016 | 4176 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2004 | 387 | 0.220 |
Why?
|
| Communicable Diseases | 2 | 2022 | 874 | 0.220 |
Why?
|
| Airway Obstruction | 4 | 2012 | 672 | 0.220 |
Why?
|
| Prevalence | 23 | 2022 | 15869 | 0.220 |
Why?
|
| Oscillometry | 1 | 2024 | 151 | 0.220 |
Why?
|
| Brain Ischemia | 2 | 2019 | 3007 | 0.210 |
Why?
|
| Immunity, Innate | 9 | 2019 | 3080 | 0.210 |
Why?
|
| Shoulder Dislocation | 1 | 2004 | 129 | 0.210 |
Why?
|
| Diabetes, Gestational | 2 | 2023 | 1263 | 0.210 |
Why?
|
| Wood | 2 | 2014 | 94 | 0.210 |
Why?
|
| Repression, Psychology | 1 | 2003 | 46 | 0.210 |
Why?
|
| Adjustment Disorders | 1 | 2003 | 68 | 0.210 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2005 | 219 | 0.210 |
Why?
|
| Magnesium | 2 | 2018 | 815 | 0.210 |
Why?
|
| rho-Associated Kinases | 1 | 2024 | 290 | 0.210 |
Why?
|
| Lipids | 6 | 2020 | 3343 | 0.200 |
Why?
|
| Signal Transduction | 14 | 2024 | 23645 | 0.200 |
Why?
|
| Ecosystem | 2 | 2017 | 494 | 0.200 |
Why?
|
| Myostatin | 1 | 2023 | 129 | 0.200 |
Why?
|
| Bronchitis | 4 | 1998 | 194 | 0.200 |
Why?
|
| Metagenome | 3 | 2022 | 465 | 0.200 |
Why?
|
| Bilirubin | 1 | 2024 | 438 | 0.200 |
Why?
|
| Patients | 1 | 2009 | 908 | 0.200 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2016 | 329 | 0.200 |
Why?
|
| Puerto Rico | 7 | 2021 | 380 | 0.200 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2009 | 862 | 0.200 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 993 | 0.200 |
Why?
|
| Risk Assessment | 16 | 2019 | 24315 | 0.200 |
Why?
|
| Anger | 3 | 2006 | 405 | 0.200 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2014 | 2185 | 0.200 |
Why?
|
| Time Factors | 36 | 2015 | 40218 | 0.200 |
Why?
|
| Benchmarking | 3 | 2023 | 1057 | 0.200 |
Why?
|
| Bacterial Toxins | 2 | 1998 | 922 | 0.200 |
Why?
|
| Sympathetic Nervous System | 3 | 1996 | 521 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2002 | 127 | 0.200 |
Why?
|
| Vasospasm, Intracranial | 1 | 2024 | 207 | 0.200 |
Why?
|
| Heat-Shock Proteins | 3 | 2009 | 797 | 0.200 |
Why?
|
| Lymphocytes | 4 | 2019 | 2614 | 0.200 |
Why?
|
| Patient Satisfaction | 4 | 2009 | 3488 | 0.200 |
Why?
|
| Insect Proteins | 3 | 2006 | 253 | 0.190 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2002 | 60 | 0.190 |
Why?
|
| Tenascin | 1 | 2022 | 61 | 0.190 |
Why?
|
| Interleukin-12 | 1 | 2004 | 577 | 0.190 |
Why?
|
| Disease Progression | 16 | 2019 | 13671 | 0.190 |
Why?
|
| Mucin-1 | 2 | 2023 | 537 | 0.190 |
Why?
|
| Vitamin E | 5 | 2008 | 874 | 0.190 |
Why?
|
| RNA | 4 | 2021 | 2720 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 4 | 2017 | 1996 | 0.190 |
Why?
|
| Tryptophan | 2 | 2024 | 482 | 0.190 |
Why?
|
| Cell Shape | 2 | 2015 | 371 | 0.190 |
Why?
|
| Immunoglobulin Joining Region | 1 | 2001 | 37 | 0.190 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 2001 | 58 | 0.190 |
Why?
|
| Immunotherapy | 1 | 2017 | 4755 | 0.190 |
Why?
|
| Rural Health | 2 | 2001 | 302 | 0.190 |
Why?
|
| Parents | 8 | 2010 | 3595 | 0.190 |
Why?
|
| DNA | 5 | 2021 | 7214 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 3514 | 0.190 |
Why?
|
| DNA-Binding Proteins | 10 | 2020 | 9615 | 0.190 |
Why?
|
| Pregnancy Tests | 1 | 2001 | 33 | 0.190 |
Why?
|
| Database Management Systems | 1 | 2003 | 263 | 0.190 |
Why?
|
| Respiratory Mucosa | 2 | 2016 | 439 | 0.190 |
Why?
|
| Prognosis | 26 | 2023 | 30010 | 0.190 |
Why?
|
| Immune System | 3 | 2017 | 799 | 0.190 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2001 | 83 | 0.190 |
Why?
|
| Bronchial Spasm | 4 | 1990 | 71 | 0.190 |
Why?
|
| Uric Acid | 4 | 2006 | 805 | 0.190 |
Why?
|
| Hydrocortisone | 6 | 2024 | 1841 | 0.190 |
Why?
|
| Geography | 1 | 2003 | 652 | 0.190 |
Why?
|
| Compressive Strength | 1 | 2022 | 159 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2023 | 12252 | 0.180 |
Why?
|
| Cell Movement | 5 | 2024 | 5210 | 0.180 |
Why?
|
| Genes | 4 | 1999 | 1824 | 0.180 |
Why?
|
| Chorioamnionitis | 2 | 2020 | 156 | 0.180 |
Why?
|
| HLA-A2 Antigen | 1 | 2021 | 207 | 0.180 |
Why?
|
| Biological Therapy | 1 | 2022 | 140 | 0.180 |
Why?
|
| Phylogeny | 6 | 2021 | 2843 | 0.180 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2017 | 702 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 8 | 2019 | 4415 | 0.180 |
Why?
|
| STAT3 Transcription Factor | 1 | 2005 | 874 | 0.180 |
Why?
|
| Maternal Behavior | 2 | 2012 | 307 | 0.180 |
Why?
|
| Phenols | 1 | 2024 | 526 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 18 | 2018 | 10760 | 0.180 |
Why?
|
| Oligonucleotides | 2 | 2021 | 563 | 0.180 |
Why?
|
| Carrier Proteins | 7 | 2019 | 4937 | 0.180 |
Why?
|
| Hemolysin Proteins | 2 | 1998 | 113 | 0.180 |
Why?
|
| Adipose Tissue | 8 | 2016 | 3329 | 0.180 |
Why?
|
| Fucosyltransferases | 1 | 2020 | 118 | 0.180 |
Why?
|
| Rhinitis | 3 | 2002 | 753 | 0.170 |
Why?
|
| DNA, Mitochondrial | 2 | 2003 | 872 | 0.170 |
Why?
|
| Alkanesulfonic Acids | 1 | 2023 | 203 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 8 | 2018 | 6231 | 0.170 |
Why?
|
| Maternal Age | 4 | 2020 | 805 | 0.170 |
Why?
|
| Environmental Pollutants | 3 | 2024 | 1296 | 0.170 |
Why?
|
| Urban Population | 9 | 2009 | 2046 | 0.170 |
Why?
|
| Common Cold | 2 | 2018 | 63 | 0.170 |
Why?
|
| Matrix Metalloproteinase 12 | 2 | 2010 | 44 | 0.170 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2015 | 638 | 0.170 |
Why?
|
| Medically Underserved Area | 1 | 2022 | 268 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2020 | 2892 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2008 | 4352 | 0.170 |
Why?
|
| Population Surveillance | 8 | 2020 | 2596 | 0.170 |
Why?
|
| Emergency Service, Hospital | 10 | 2014 | 7951 | 0.170 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2022 | 179 | 0.170 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2000 | 82 | 0.170 |
Why?
|
| Chromatography, Liquid | 5 | 2023 | 996 | 0.170 |
Why?
|
| Abortion, Legal | 1 | 2001 | 121 | 0.170 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2013 | 606 | 0.170 |
Why?
|
| Disease Management | 5 | 2020 | 2536 | 0.170 |
Why?
|
| Antioxidants | 5 | 2006 | 1673 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 9 | 2024 | 7454 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2018 | 3251 | 0.170 |
Why?
|
| Splints | 1 | 2000 | 108 | 0.170 |
Why?
|
| Transcription Factors | 10 | 2016 | 12168 | 0.170 |
Why?
|
| Cats | 8 | 2003 | 978 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2017 | 1367 | 0.170 |
Why?
|
| Nitrogen Dioxide | 3 | 2019 | 534 | 0.160 |
Why?
|
| Muscle Contraction | 1 | 2004 | 1209 | 0.160 |
Why?
|
| Down-Regulation | 6 | 2024 | 2937 | 0.160 |
Why?
|
| Calcitriol | 2 | 2012 | 303 | 0.160 |
Why?
|
| Hypertension | 14 | 2006 | 8616 | 0.160 |
Why?
|
| Glycine Hydroxymethyltransferase | 2 | 2012 | 34 | 0.160 |
Why?
|
| Cockroaches | 9 | 2006 | 92 | 0.160 |
Why?
|
| Immunization | 2 | 2017 | 1219 | 0.160 |
Why?
|
| Paraproteinemias | 1 | 2022 | 252 | 0.160 |
Why?
|
| beta-Globins | 1 | 2019 | 111 | 0.160 |
Why?
|
| Ethanolamines | 1 | 2019 | 152 | 0.160 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 1672 | 0.160 |
Why?
|
| Physicians, Family | 3 | 2009 | 349 | 0.160 |
Why?
|
| Lysine | 1 | 2024 | 1000 | 0.160 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2003 | 1441 | 0.160 |
Why?
|
| Haemophilus influenzae | 1 | 2019 | 177 | 0.160 |
Why?
|
| Chorionic Gonadotropin | 1 | 2001 | 458 | 0.160 |
Why?
|
| Desensitization, Immunologic | 1 | 2024 | 558 | 0.160 |
Why?
|
| Metals, Heavy | 1 | 2020 | 149 | 0.160 |
Why?
|
| Carbon Dioxide | 2 | 2023 | 1148 | 0.160 |
Why?
|
| Statistics as Topic | 5 | 2016 | 2357 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 4580 | 0.160 |
Why?
|
| Hemolysis | 1 | 2021 | 417 | 0.160 |
Why?
|
| Austria | 3 | 2015 | 208 | 0.160 |
Why?
|
| Type A Personality | 1 | 1998 | 24 | 0.160 |
Why?
|
| Placebo Effect | 2 | 2020 | 517 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 2 | 2023 | 873 | 0.160 |
Why?
|
| Age Distribution | 12 | 2009 | 2873 | 0.160 |
Why?
|
| Molecular Sequence Data | 11 | 2011 | 17622 | 0.160 |
Why?
|
| Homocysteine | 2 | 2012 | 637 | 0.160 |
Why?
|
| Intention to Treat Analysis | 1 | 2020 | 416 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2018 | 247 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 7 | 2017 | 1737 | 0.150 |
Why?
|
| Nasal Mucosa | 2 | 2020 | 416 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 353 | 0.150 |
Why?
|
| Health Education | 3 | 1995 | 1059 | 0.150 |
Why?
|
| Carbon Monoxide | 3 | 2019 | 560 | 0.150 |
Why?
|
| Murine hepatitis virus | 2 | 1995 | 19 | 0.150 |
Why?
|
| 3' Untranslated Regions | 4 | 2014 | 515 | 0.150 |
Why?
|
| Telomere | 2 | 2024 | 944 | 0.150 |
Why?
|
| Hand Strength | 2 | 2000 | 466 | 0.150 |
Why?
|
| Interleukin-2 | 2 | 2024 | 1895 | 0.150 |
Why?
|
| Body Composition | 6 | 1997 | 2462 | 0.150 |
Why?
|
| Smad2 Protein | 1 | 2018 | 144 | 0.150 |
Why?
|
| Educational Status | 7 | 2023 | 2515 | 0.150 |
Why?
|
| Thumb | 1 | 2000 | 232 | 0.150 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 381 | 0.150 |
Why?
|
| Helminths | 1 | 1998 | 39 | 0.150 |
Why?
|
| Fracture Healing | 2 | 2011 | 448 | 0.150 |
Why?
|
| Statistics, Nonparametric | 2 | 2003 | 2862 | 0.150 |
Why?
|
| Immunoassay | 2 | 2020 | 746 | 0.150 |
Why?
|
| Cerebellar Nuclei | 1 | 2018 | 54 | 0.150 |
Why?
|
| Vitamin D-Binding Protein | 2 | 2021 | 130 | 0.150 |
Why?
|
| Netherlands | 17 | 2016 | 2277 | 0.150 |
Why?
|
| Benzhydryl Compounds | 1 | 2024 | 944 | 0.150 |
Why?
|
| Measles | 1 | 2000 | 180 | 0.150 |
Why?
|
| Depression, Postpartum | 1 | 2022 | 355 | 0.150 |
Why?
|
| Range of Motion, Articular | 1 | 2004 | 1597 | 0.150 |
Why?
|
| Body Image | 1 | 2003 | 646 | 0.150 |
Why?
|
| Pulmonary Alveoli | 3 | 2010 | 665 | 0.150 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2007 | 1361 | 0.150 |
Why?
|
| Population Density | 3 | 2021 | 193 | 0.140 |
Why?
|
| Problem Solving | 1 | 2020 | 443 | 0.140 |
Why?
|
| Antigen Presentation | 3 | 1998 | 1251 | 0.140 |
Why?
|
| Women | 1 | 1999 | 225 | 0.140 |
Why?
|
| Cough | 7 | 2019 | 598 | 0.140 |
Why?
|
| Species Specificity | 3 | 2017 | 2415 | 0.140 |
Why?
|
| Sphingosine | 1 | 2019 | 308 | 0.140 |
Why?
|
| Microbial Interactions | 1 | 2017 | 74 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2023 | 506 | 0.140 |
Why?
|
| Peptide Fragments | 1 | 2010 | 5151 | 0.140 |
Why?
|
| Bone and Bones | 9 | 2003 | 2589 | 0.140 |
Why?
|
| Calcitonin | 2 | 2008 | 328 | 0.140 |
Why?
|
| Information Storage and Retrieval | 1 | 2003 | 830 | 0.140 |
Why?
|
| Triclosan | 1 | 2017 | 58 | 0.140 |
Why?
|
| Fossil Fuels | 1 | 1997 | 53 | 0.140 |
Why?
|
| Sputum | 2 | 2021 | 517 | 0.140 |
Why?
|
| Cholesterol, HDL | 5 | 2018 | 1820 | 0.140 |
Why?
|
| Lysophospholipids | 1 | 2019 | 338 | 0.140 |
Why?
|
| Internationality | 1 | 2022 | 1008 | 0.140 |
Why?
|
| Epidemiologic Methods | 6 | 2001 | 1328 | 0.140 |
Why?
|
| Air Pollution | 4 | 2023 | 2374 | 0.140 |
Why?
|
| Cysteine Endopeptidases | 4 | 2015 | 542 | 0.140 |
Why?
|
| Protein Precursors | 3 | 2008 | 1134 | 0.140 |
Why?
|
| Proportional Hazards Models | 10 | 2019 | 12543 | 0.140 |
Why?
|
| Genome, Viral | 1 | 2021 | 674 | 0.140 |
Why?
|
| Parabens | 1 | 2017 | 118 | 0.140 |
Why?
|
| Sensitivity and Specificity | 15 | 2024 | 14729 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 22379 | 0.140 |
Why?
|
| Sex Distribution | 9 | 2003 | 2278 | 0.140 |
Why?
|
| Heroin Dependence | 1 | 2017 | 173 | 0.140 |
Why?
|
| Receptors, Immunologic | 3 | 2022 | 1418 | 0.130 |
Why?
|
| Genes, MHC Class I | 1 | 1997 | 235 | 0.130 |
Why?
|
| Globus Pallidus | 1 | 2018 | 248 | 0.130 |
Why?
|
| Immunomodulation | 2 | 2024 | 549 | 0.130 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 382 | 0.130 |
Why?
|
| Listeria monocytogenes | 1 | 1998 | 246 | 0.130 |
Why?
|
| Arabs | 1 | 1999 | 190 | 0.130 |
Why?
|
| Smoke | 2 | 2023 | 242 | 0.130 |
Why?
|
| Glycolysis | 1 | 2020 | 837 | 0.130 |
Why?
|
| Administration, Oral | 7 | 2024 | 4030 | 0.130 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 1712 | 0.130 |
Why?
|
| Mites | 6 | 2002 | 46 | 0.130 |
Why?
|
| Primary Prevention | 2 | 2014 | 1188 | 0.130 |
Why?
|
| HLA Antigens | 3 | 2018 | 1334 | 0.130 |
Why?
|
| Child Day Care Centers | 3 | 2002 | 122 | 0.130 |
Why?
|
| Cell Differentiation | 7 | 2010 | 11669 | 0.130 |
Why?
|
| Social Environment | 4 | 1994 | 1012 | 0.130 |
Why?
|
| Leukotrienes | 4 | 2018 | 232 | 0.130 |
Why?
|
| Age of Onset | 8 | 2015 | 3347 | 0.130 |
Why?
|
| Herpes Zoster | 1 | 2018 | 252 | 0.130 |
Why?
|
| Databases, Factual | 5 | 2024 | 8080 | 0.130 |
Why?
|
| Delivery of Health Care | 7 | 2020 | 5367 | 0.130 |
Why?
|
| Pneumococcal Infections | 1 | 2020 | 529 | 0.130 |
Why?
|
| Socioeconomic Factors | 14 | 2012 | 7852 | 0.130 |
Why?
|
| Housing | 4 | 2005 | 683 | 0.130 |
Why?
|
| Chronic Disease | 11 | 2016 | 9384 | 0.130 |
Why?
|
| Androgens | 1 | 2023 | 1281 | 0.130 |
Why?
|
| Evolution, Molecular | 2 | 2003 | 1896 | 0.130 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2015 | 44 | 0.130 |
Why?
|
| Utilization Review | 2 | 2015 | 381 | 0.130 |
Why?
|
| Occupational Diseases | 8 | 2006 | 1457 | 0.130 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2014 | 371 | 0.130 |
Why?
|
| Resuscitation | 1 | 2000 | 679 | 0.130 |
Why?
|
| Glutathione Transferase | 2 | 2010 | 564 | 0.130 |
Why?
|
| Serpin E2 | 3 | 2011 | 48 | 0.130 |
Why?
|
| B-Lymphocytes | 3 | 2015 | 4793 | 0.130 |
Why?
|
| Cells, Cultured | 14 | 2018 | 19015 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2021 | 2145 | 0.130 |
Why?
|
| Proprotein Convertase 1 | 1 | 2015 | 10 | 0.120 |
Why?
|
| Hypertrophy | 2 | 2010 | 562 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2830 | 0.120 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2011 | 174 | 0.120 |
Why?
|
| Dermatophagoides farinae | 1 | 2015 | 19 | 0.120 |
Why?
|
| alpha Catenin | 1 | 2015 | 37 | 0.120 |
Why?
|
| Chemokines | 2 | 2020 | 963 | 0.120 |
Why?
|
| Overweight | 3 | 2018 | 2448 | 0.120 |
Why?
|
| Ankyrin Repeat | 1 | 2015 | 19 | 0.120 |
Why?
|
| Cohort Effect | 1 | 1995 | 39 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 3114 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 2909 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2015 | 313 | 0.120 |
Why?
|
| Office Visits | 4 | 2015 | 595 | 0.120 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2015 | 53 | 0.120 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 542 | 0.120 |
Why?
|
| Aneurysm | 1 | 2018 | 343 | 0.120 |
Why?
|
| Folic Acid Deficiency | 1 | 2016 | 117 | 0.120 |
Why?
|
| Mice, Inbred DBA | 2 | 2015 | 624 | 0.120 |
Why?
|
| Bronchiolitis, Viral | 2 | 2014 | 82 | 0.120 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2017 | 352 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 2006 | 243 | 0.120 |
Why?
|
| Semaphorins | 1 | 2015 | 96 | 0.120 |
Why?
|
| Acetaminophen | 2 | 2014 | 552 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 369 | 0.120 |
Why?
|
| alpha-N-Acetylgalactosaminidase | 1 | 2014 | 4 | 0.120 |
Why?
|
| Mucus | 2 | 2019 | 346 | 0.120 |
Why?
|
| Amides | 1 | 2017 | 451 | 0.120 |
Why?
|
| Anthropometry | 8 | 2022 | 1346 | 0.120 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1998 | 1353 | 0.120 |
Why?
|
| Personality Development | 2 | 1992 | 241 | 0.120 |
Why?
|
| Anxiety | 4 | 2015 | 4672 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2020 | 724 | 0.120 |
Why?
|
| Salmonella Infections, Animal | 1 | 2014 | 60 | 0.120 |
Why?
|
| Serotonin | 3 | 1998 | 1043 | 0.120 |
Why?
|
| Orthopedic Procedures | 1 | 2004 | 1279 | 0.120 |
Why?
|
| Drug Therapy | 2 | 2008 | 504 | 0.120 |
Why?
|
| Smoking Cessation | 3 | 2017 | 2085 | 0.120 |
Why?
|
| Antibiosis | 1 | 2014 | 46 | 0.120 |
Why?
|
| Fever | 3 | 2008 | 1614 | 0.120 |
Why?
|
| Shock, Septic | 1 | 2021 | 774 | 0.110 |
Why?
|
| Nutritional Status | 3 | 2023 | 1628 | 0.110 |
Why?
|
| Pacifiers | 1 | 2013 | 12 | 0.110 |
Why?
|
| Stress, Psychological | 6 | 2015 | 4530 | 0.110 |
Why?
|
| Exons | 7 | 2018 | 2394 | 0.110 |
Why?
|
| International Classification of Diseases | 3 | 2016 | 937 | 0.110 |
Why?
|
| Retrospective Studies | 25 | 2024 | 81762 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2015 | 178 | 0.110 |
Why?
|
| Chemokine CXCL5 | 1 | 2013 | 27 | 0.110 |
Why?
|
| Peak Expiratory Flow Rate | 6 | 2004 | 144 | 0.110 |
Why?
|
| Fatty Acid Desaturases | 1 | 2014 | 102 | 0.110 |
Why?
|
| Biological Evolution | 1 | 2000 | 1076 | 0.110 |
Why?
|
| Epinephrine | 3 | 1994 | 794 | 0.110 |
Why?
|
| Sulfides | 3 | 2012 | 171 | 0.110 |
Why?
|
| Copper | 3 | 2005 | 368 | 0.110 |
Why?
|
| Europe | 4 | 2022 | 3436 | 0.110 |
Why?
|
| beta 2-Microglobulin | 1 | 1995 | 330 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1997 | 567 | 0.110 |
Why?
|
| Critical Illness | 3 | 2022 | 2756 | 0.110 |
Why?
|
| Mitochondria | 1 | 2007 | 3681 | 0.110 |
Why?
|
| Drug Administration Schedule | 8 | 2007 | 4860 | 0.110 |
Why?
|
| Chemokine CXCL2 | 1 | 2013 | 105 | 0.110 |
Why?
|
| Proteomics | 2 | 2023 | 3912 | 0.110 |
Why?
|
| Alternative Splicing | 4 | 2016 | 1105 | 0.110 |
Why?
|
| Hospitalization | 12 | 2022 | 10840 | 0.110 |
Why?
|
| Gene Dosage | 2 | 2008 | 1219 | 0.110 |
Why?
|
| Hematopoiesis | 1 | 2023 | 2059 | 0.110 |
Why?
|
| Neuropeptides | 1 | 2019 | 951 | 0.110 |
Why?
|
| Normal Distribution | 1 | 2014 | 272 | 0.110 |
Why?
|
| T-Lymphocytes | 8 | 2020 | 10266 | 0.110 |
Why?
|
| Cholesterol, LDL | 9 | 2018 | 2403 | 0.110 |
Why?
|
| Calcium | 4 | 2018 | 5792 | 0.110 |
Why?
|
| Aspergillus niger | 1 | 2013 | 18 | 0.110 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 208 | 0.110 |
Why?
|
| Chemokine CXCL1 | 1 | 2013 | 102 | 0.110 |
Why?
|
| Forecasting | 4 | 2015 | 2945 | 0.110 |
Why?
|
| Hypolipidemic Agents | 1 | 2018 | 609 | 0.110 |
Why?
|
| Cyclopropanes | 3 | 2012 | 436 | 0.110 |
Why?
|
| Environment | 5 | 2016 | 1121 | 0.110 |
Why?
|
| Data Collection | 5 | 2023 | 3327 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2012 | 350 | 0.110 |
Why?
|
| Leishmania major | 1 | 2013 | 60 | 0.110 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 620 | 0.110 |
Why?
|
| Confidence Intervals | 9 | 2017 | 2923 | 0.110 |
Why?
|
| Calcifediol | 3 | 2023 | 160 | 0.110 |
Why?
|
| Prednisolone | 1 | 2014 | 326 | 0.110 |
Why?
|
| Ibuprofen | 1 | 2014 | 229 | 0.110 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2001 | 1772 | 0.110 |
Why?
|
| Thiophenes | 1 | 2017 | 570 | 0.100 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2015 | 453 | 0.100 |
Why?
|
| Self Report | 1 | 2024 | 3773 | 0.100 |
Why?
|
| Leukotriene E4 | 2 | 2012 | 75 | 0.100 |
Why?
|
| Weaning | 1 | 2013 | 102 | 0.100 |
Why?
|
| Biometry | 3 | 2007 | 570 | 0.100 |
Why?
|
| Hyperlipidemias | 2 | 2013 | 772 | 0.100 |
Why?
|
| gamma-Glutamyl Hydrolase | 1 | 2012 | 8 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2017 | 910 | 0.100 |
Why?
|
| Catecholamines | 1 | 1993 | 389 | 0.100 |
Why?
|
| Diabetes Mellitus | 3 | 2022 | 5889 | 0.100 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2013 | 48 | 0.100 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 1837 | 0.100 |
Why?
|
| Porphobilinogen Synthase | 2 | 2003 | 29 | 0.100 |
Why?
|
| Systems Integration | 1 | 2014 | 430 | 0.100 |
Why?
|
| Cell Proliferation | 10 | 2024 | 10474 | 0.100 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2018 | 454 | 0.100 |
Why?
|
| Phobic Disorders | 1 | 1995 | 441 | 0.100 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2012 | 276 | 0.100 |
Why?
|
| Liver | 5 | 2021 | 7577 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 3 | 2012 | 1088 | 0.100 |
Why?
|
| HLA-DQ Antigens | 1 | 2012 | 190 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2020 | 1027 | 0.100 |
Why?
|
| Arthrogryposis | 1 | 2013 | 69 | 0.100 |
Why?
|
| Immobilization | 1 | 1993 | 229 | 0.100 |
Why?
|
| Osteoarthritis | 1 | 2000 | 1072 | 0.100 |
Why?
|
| Mice, Knockout | 8 | 2021 | 14488 | 0.100 |
Why?
|
| Cadherins | 1 | 2017 | 905 | 0.100 |
Why?
|
| Bronchial Diseases | 3 | 1987 | 151 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1338 | 0.100 |
Why?
|
| Physical Stimulation | 1 | 2013 | 517 | 0.100 |
Why?
|
| Rural Population | 9 | 2002 | 2325 | 0.100 |
Why?
|
| Intubation, Intratracheal | 1 | 2000 | 1359 | 0.100 |
Why?
|
| Cesarean Section | 3 | 2022 | 1425 | 0.100 |
Why?
|
| Heterozygote | 3 | 2021 | 2798 | 0.100 |
Why?
|
| Iron | 3 | 2019 | 1813 | 0.100 |
Why?
|
| Bony Callus | 1 | 2011 | 41 | 0.100 |
Why?
|
| Mass Spectrometry | 4 | 2022 | 2202 | 0.100 |
Why?
|
| Fetal Proteins | 1 | 2012 | 100 | 0.100 |
Why?
|
| Quality of Life | 7 | 2012 | 13490 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2020 | 2907 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 251 | 0.100 |
Why?
|
| Cytochromes b | 1 | 2011 | 35 | 0.100 |
Why?
|
| Fathers | 3 | 2005 | 377 | 0.100 |
Why?
|
| Patient Compliance | 4 | 2010 | 2697 | 0.100 |
Why?
|
| Solubility | 2 | 2008 | 1083 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3589 | 0.100 |
Why?
|
| Heart Rate | 3 | 2005 | 4214 | 0.100 |
Why?
|
| Norepinephrine | 5 | 1996 | 898 | 0.100 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 170 | 0.090 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2013 | 137 | 0.090 |
Why?
|
| Obstetric Labor, Premature | 1 | 1993 | 268 | 0.090 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2014 | 149 | 0.090 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2012 | 162 | 0.090 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2012 | 78 | 0.090 |
Why?
|
| STAT6 Transcription Factor | 1 | 2011 | 196 | 0.090 |
Why?
|
| 18-Hydroxycorticosterone | 1 | 1991 | 3 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2022 | 1541 | 0.090 |
Why?
|
| Zinc Fingers | 1 | 2013 | 577 | 0.090 |
Why?
|
| Kallikreins | 1 | 2012 | 219 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2021 | 4063 | 0.090 |
Why?
|
| Leukopenia | 1 | 1991 | 212 | 0.090 |
Why?
|
| Fishes | 1 | 1994 | 606 | 0.090 |
Why?
|
| Classification | 1 | 2011 | 128 | 0.090 |
Why?
|
| Social Support | 3 | 2013 | 2193 | 0.090 |
Why?
|
| Tandem Repeat Sequences | 2 | 2002 | 183 | 0.090 |
Why?
|
| Cold Temperature | 8 | 1989 | 791 | 0.090 |
Why?
|
| Pulmonary Emphysema | 2 | 2015 | 689 | 0.090 |
Why?
|
| Attitude | 3 | 1992 | 771 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 1892 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2000 | 1388 | 0.090 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2009 | 306 | 0.090 |
Why?
|
| Lymphoma | 1 | 2020 | 1898 | 0.090 |
Why?
|
| Allylamine | 2 | 2001 | 10 | 0.090 |
Why?
|
| Posture | 2 | 1986 | 957 | 0.090 |
Why?
|
| Cell Nucleus | 3 | 2015 | 2885 | 0.090 |
Why?
|
| Glycoproteins | 8 | 2008 | 2202 | 0.090 |
Why?
|
| Alcohol Amnestic Disorder | 1 | 1990 | 35 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 4786 | 0.090 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 1001 | 0.090 |
Why?
|
| Electrocardiography | 7 | 2010 | 6412 | 0.090 |
Why?
|
| Likelihood Functions | 4 | 2016 | 994 | 0.090 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 1298 | 0.090 |
Why?
|
| Ambulatory Care | 2 | 2001 | 2783 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 3533 | 0.090 |
Why?
|
| DNA Mutational Analysis | 6 | 2021 | 4120 | 0.090 |
Why?
|
| Alcian Blue | 1 | 2010 | 13 | 0.090 |
Why?
|
| Intestines | 2 | 2016 | 1909 | 0.090 |
Why?
|
| Referral and Consultation | 2 | 2016 | 3620 | 0.090 |
Why?
|
| Biodiversity | 3 | 2018 | 345 | 0.090 |
Why?
|
| Collagen Type X | 1 | 2010 | 16 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1703 | 0.090 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2006 | 1117 | 0.090 |
Why?
|
| Primary Health Care | 3 | 2022 | 4746 | 0.090 |
Why?
|
| Lung Volume Measurements | 6 | 1997 | 381 | 0.090 |
Why?
|
| Leukocytosis | 1 | 1991 | 251 | 0.090 |
Why?
|
| alpha-2-Antiplasmin | 1 | 2010 | 13 | 0.090 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2010 | 53 | 0.090 |
Why?
|
| Perinatal Care | 1 | 2013 | 245 | 0.090 |
Why?
|
| Fluorescence | 2 | 2005 | 756 | 0.090 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2021 | 737 | 0.090 |
Why?
|
| Patella | 4 | 2007 | 317 | 0.090 |
Why?
|
| Radionuclide Imaging | 2 | 1999 | 2000 | 0.090 |
Why?
|
| Dogs | 5 | 2020 | 3845 | 0.090 |
Why?
|
| Bacterial Infections | 2 | 2008 | 1397 | 0.090 |
Why?
|
| Plants, Toxic | 2 | 1996 | 70 | 0.090 |
Why?
|
| Methylprednisolone | 2 | 2008 | 386 | 0.090 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 1 | 2010 | 15 | 0.090 |
Why?
|
| Alkaline Phosphatase | 3 | 2010 | 863 | 0.090 |
Why?
|
| Stem Cells | 2 | 2000 | 3537 | 0.090 |
Why?
|
| North America | 4 | 2021 | 1289 | 0.090 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3115 | 0.090 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1992 | 239 | 0.090 |
Why?
|
| Genes, MHC Class II | 1 | 1991 | 433 | 0.090 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2010 | 101 | 0.090 |
Why?
|
| Birth Weight | 5 | 2012 | 2121 | 0.080 |
Why?
|
| Family Nursing | 1 | 2009 | 20 | 0.080 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 398 | 0.080 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1991 | 289 | 0.080 |
Why?
|
| Warfarin | 1 | 2018 | 1493 | 0.080 |
Why?
|
| Egg Proteins | 1 | 2009 | 58 | 0.080 |
Why?
|
| Drug Design | 2 | 2005 | 1046 | 0.080 |
Why?
|
| Cost Savings | 1 | 2015 | 904 | 0.080 |
Why?
|
| Epilepsy | 2 | 2022 | 3327 | 0.080 |
Why?
|
| Theophylline | 2 | 2008 | 133 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2010 | 205 | 0.080 |
Why?
|
| Nicotine | 1 | 2014 | 680 | 0.080 |
Why?
|
| Systole | 4 | 2003 | 937 | 0.080 |
Why?
|
| Collagen Type II | 1 | 2010 | 151 | 0.080 |
Why?
|
| Hypercholesterolemia | 4 | 2001 | 1145 | 0.080 |
Why?
|
| Ionomycin | 1 | 2009 | 110 | 0.080 |
Why?
|
| Hypoglycemic Agents | 3 | 2017 | 3109 | 0.080 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 527 | 0.080 |
Why?
|
| Alendronate | 2 | 2001 | 174 | 0.080 |
Why?
|
| Serum Albumin | 1 | 1992 | 677 | 0.080 |
Why?
|
| Health Maintenance Organizations | 3 | 2001 | 657 | 0.080 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2021 | 331 | 0.080 |
Why?
|
| Fasting | 5 | 1998 | 1610 | 0.080 |
Why?
|
| Psychotropic Drugs | 1 | 1995 | 881 | 0.080 |
Why?
|
| Thrombospondins | 1 | 2010 | 196 | 0.080 |
Why?
|
| Protein Kinase C-alpha | 1 | 2009 | 113 | 0.080 |
Why?
|
| Medical Informatics | 1 | 2016 | 743 | 0.080 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2011 | 355 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 3671 | 0.080 |
Why?
|
| Leukocytes | 2 | 2017 | 2035 | 0.080 |
Why?
|
| G-Protein-Coupled Receptor Kinase 5 | 1 | 2008 | 5 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2004 | 640 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2014 | 812 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2009 | 534 | 0.080 |
Why?
|
| Mice, SCID | 3 | 2010 | 2627 | 0.080 |
Why?
|
| Comorbidity | 9 | 2017 | 10590 | 0.080 |
Why?
|
| Triglycerides | 7 | 2000 | 2464 | 0.080 |
Why?
|
| Intermediate Filament Proteins | 2 | 2007 | 261 | 0.080 |
Why?
|
| Heart Diseases | 2 | 2009 | 2819 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 2442 | 0.080 |
Why?
|
| Medication Therapy Management | 1 | 2010 | 131 | 0.080 |
Why?
|
| Azathioprine | 1 | 2010 | 354 | 0.080 |
Why?
|
| Sphingomyelins | 2 | 2023 | 105 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 2 | 2012 | 1363 | 0.080 |
Why?
|
| Drug Utilization | 4 | 2005 | 1189 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2014 | 1530 | 0.080 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1994 | 747 | 0.080 |
Why?
|
| Introns | 4 | 2009 | 966 | 0.080 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2010 | 305 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2017 | 1596 | 0.080 |
Why?
|
| Receptors, Leukotriene | 1 | 2009 | 97 | 0.080 |
Why?
|
| Alcoholic Intoxication | 2 | 1990 | 171 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 2298 | 0.080 |
Why?
|
| Chemokine CCL11 | 2 | 2006 | 128 | 0.080 |
Why?
|
| Bone Density | 5 | 2012 | 3573 | 0.080 |
Why?
|
| Rats | 11 | 2012 | 23760 | 0.080 |
Why?
|
| Genetic Techniques | 2 | 2008 | 428 | 0.080 |
Why?
|
| Poly C | 1 | 2007 | 6 | 0.080 |
Why?
|
| Canada | 4 | 2012 | 2130 | 0.080 |
Why?
|
| Creatinine | 6 | 2003 | 1918 | 0.080 |
Why?
|
| Arachidonate 5-Lipoxygenase | 2 | 2006 | 128 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2004 | 3463 | 0.080 |
Why?
|
| Deafness | 3 | 1998 | 460 | 0.080 |
Why?
|
| Ion Channels | 1 | 2013 | 1043 | 0.070 |
Why?
|
| Verbal Learning | 1 | 1990 | 465 | 0.070 |
Why?
|
| Immunoglobulin G | 3 | 2007 | 4568 | 0.070 |
Why?
|
| Sampling Studies | 4 | 2003 | 615 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2017 | 9263 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 1998 | 4648 | 0.070 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2013 | 541 | 0.070 |
Why?
|
| Gene Order | 2 | 2007 | 166 | 0.070 |
Why?
|
| Indians, Central American | 1 | 2007 | 19 | 0.070 |
Why?
|
| Causality | 3 | 2001 | 1254 | 0.070 |
Why?
|
| Tibia | 5 | 2007 | 1076 | 0.070 |
Why?
|
| Cromolyn Sodium | 4 | 2001 | 78 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2010 | 565 | 0.070 |
Why?
|
| Fats | 1 | 2008 | 99 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 832 | 0.070 |
Why?
|
| Skinfold Thickness | 3 | 2012 | 164 | 0.070 |
Why?
|
| Tibial Fractures | 1 | 2010 | 276 | 0.070 |
Why?
|
| Drug Prescriptions | 3 | 2008 | 1668 | 0.070 |
Why?
|
| Cell Extracts | 1 | 1987 | 135 | 0.070 |
Why?
|
| House Calls | 1 | 2009 | 171 | 0.070 |
Why?
|
| Sodium | 2 | 1994 | 1597 | 0.070 |
Why?
|
| Potassium | 1 | 1991 | 1315 | 0.070 |
Why?
|
| Delayed-Action Preparations | 2 | 2010 | 969 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 6 | 2018 | 6082 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2021 | 1228 | 0.070 |
Why?
|
| Chi-Square Distribution | 5 | 2004 | 3436 | 0.070 |
Why?
|
| Massachusetts | 12 | 2014 | 8890 | 0.070 |
Why?
|
| Membrane Potentials | 1 | 2010 | 1090 | 0.070 |
Why?
|
| Hep G2 Cells | 2 | 2021 | 378 | 0.070 |
Why?
|
| Culture Media | 1 | 2009 | 898 | 0.070 |
Why?
|
| Tretinoin | 1 | 2010 | 524 | 0.070 |
Why?
|
| Peptidoglycan | 2 | 2006 | 246 | 0.070 |
Why?
|
| Forced Expiratory Flow Rates | 6 | 2017 | 75 | 0.070 |
Why?
|
| Brazil | 2 | 2021 | 1250 | 0.070 |
Why?
|
| Agriculture | 2 | 2012 | 186 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2023 | 1197 | 0.070 |
Why?
|
| Selection Bias | 2 | 2001 | 360 | 0.070 |
Why?
|
| Probability | 5 | 2004 | 2479 | 0.070 |
Why?
|
| Genetic Privacy | 1 | 2007 | 59 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1995 | 1567 | 0.070 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3729 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2006 | 348 | 0.070 |
Why?
|
| Social Class | 3 | 2005 | 2008 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2024 | 801 | 0.070 |
Why?
|
| Femoral Fractures | 1 | 2010 | 376 | 0.070 |
Why?
|
| Germ Cells | 2 | 2021 | 644 | 0.070 |
Why?
|
| NF-kappa B | 3 | 2017 | 2493 | 0.070 |
Why?
|
| Mortality | 2 | 1995 | 2911 | 0.070 |
Why?
|
| Demography | 4 | 2017 | 1641 | 0.070 |
Why?
|
| Adult Children | 2 | 2003 | 104 | 0.070 |
Why?
|
| Adrenal Glands | 2 | 2024 | 557 | 0.070 |
Why?
|
| Family Practice | 1 | 2009 | 509 | 0.070 |
Why?
|
| Amino Acid Substitution | 3 | 2005 | 1743 | 0.070 |
Why?
|
| Mutation | 8 | 2023 | 30238 | 0.070 |
Why?
|
| Codon, Nonsense | 1 | 2007 | 287 | 0.070 |
Why?
|
| Semantics | 1 | 1990 | 618 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2011 | 1989 | 0.070 |
Why?
|
| Anti-Allergic Agents | 1 | 2007 | 156 | 0.070 |
Why?
|
| Rats, Wistar | 1 | 2010 | 1888 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1996 | 1243 | 0.060 |
Why?
|
| Mesoderm | 1 | 2009 | 679 | 0.060 |
Why?
|
| 3T3 Cells | 2 | 2009 | 1084 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2009 | 753 | 0.060 |
Why?
|
| Leukemia | 1 | 2014 | 1519 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 18349 | 0.060 |
Why?
|
| Ovalbumin | 2 | 2018 | 677 | 0.060 |
Why?
|
| State Health Plans | 1 | 2008 | 220 | 0.060 |
Why?
|
| Basophils | 2 | 2021 | 407 | 0.060 |
Why?
|
| Angina Pectoris | 3 | 1997 | 957 | 0.060 |
Why?
|
| Frameshift Mutation | 1 | 2007 | 392 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2010 | 1081 | 0.060 |
Why?
|
| Elastin | 2 | 2005 | 299 | 0.060 |
Why?
|
| Genetics, Medical | 1 | 2008 | 334 | 0.060 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 1876 | 0.060 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2005 | 13 | 0.060 |
Why?
|
| Hypertriglyceridemia | 2 | 1999 | 293 | 0.060 |
Why?
|
| Cardiomegaly | 2 | 1985 | 591 | 0.060 |
Why?
|
| Glucose | 2 | 2020 | 4352 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2011 | 378 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2010 | 8128 | 0.060 |
Why?
|
| Th1 Cells | 3 | 2005 | 1042 | 0.060 |
Why?
|
| Suburban Population | 1 | 2005 | 54 | 0.060 |
Why?
|
| Interleukin-17 | 2 | 2017 | 924 | 0.060 |
Why?
|
| Long Interspersed Nucleotide Elements | 2 | 2021 | 332 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2011 | 1145 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 2631 | 0.060 |
Why?
|
| Sulfonamides | 2 | 2013 | 1982 | 0.060 |
Why?
|
| Perception | 1 | 1992 | 1209 | 0.060 |
Why?
|
| Toll-Like Receptors | 3 | 2004 | 582 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 1 | 1993 | 1191 | 0.060 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2008 | 348 | 0.060 |
Why?
|
| Up-Regulation | 4 | 2018 | 4146 | 0.060 |
Why?
|
| Organ Specificity | 3 | 2016 | 1968 | 0.060 |
Why?
|
| Medicaid | 3 | 2008 | 2840 | 0.060 |
Why?
|
| Homozygote | 3 | 2018 | 1779 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 1998 | 3840 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2020 | 3409 | 0.060 |
Why?
|
| Motivation | 1 | 1995 | 2020 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2007 | 1497 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 633 | 0.060 |
Why?
|
| Least-Squares Analysis | 3 | 2017 | 367 | 0.060 |
Why?
|
| Molecular Probes | 2 | 2005 | 309 | 0.060 |
Why?
|
| Heart | 2 | 2010 | 4446 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2002 | 313 | 0.060 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2003 | 199 | 0.060 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2004 | 29 | 0.060 |
Why?
|
| Toll-Like Receptor 10 | 1 | 2004 | 12 | 0.060 |
Why?
|
| Propensity Score | 3 | 2018 | 1969 | 0.060 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 507 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2010 | 845 | 0.060 |
Why?
|
| Serpins | 1 | 2006 | 246 | 0.060 |
Why?
|
| Random Allocation | 6 | 1994 | 2396 | 0.060 |
Why?
|
| Catalytic Domain | 2 | 2005 | 699 | 0.060 |
Why?
|
| Contrast Media | 1 | 2018 | 5330 | 0.060 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2006 | 225 | 0.060 |
Why?
|
| Quebec | 1 | 2004 | 139 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2010 | 1133 | 0.060 |
Why?
|
| Medical Records | 2 | 2007 | 1410 | 0.060 |
Why?
|
| Cholesterol | 6 | 2000 | 2914 | 0.060 |
Why?
|
| Transfection | 4 | 2002 | 5755 | 0.060 |
Why?
|
| Actins | 1 | 2011 | 2064 | 0.060 |
Why?
|
| Cost Sharing | 1 | 2008 | 409 | 0.060 |
Why?
|
| Sweden | 2 | 2021 | 1382 | 0.060 |
Why?
|
| Cysteine | 1 | 2009 | 897 | 0.060 |
Why?
|
| DNA Replication | 2 | 2021 | 1427 | 0.060 |
Why?
|
| Teaching | 1 | 1992 | 1171 | 0.060 |
Why?
|
| Histidine | 1 | 2004 | 301 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 1942 | 0.060 |
Why?
|
| Siberia | 1 | 2003 | 30 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 843 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 5196 | 0.060 |
Why?
|
| Peptides | 4 | 2007 | 4354 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2001 | 547 | 0.060 |
Why?
|
| Mental Recall | 1 | 1990 | 1226 | 0.060 |
Why?
|
| Silk | 2 | 2001 | 93 | 0.060 |
Why?
|
| Endocrine System | 1 | 2024 | 113 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 2 | 2012 | 2463 | 0.060 |
Why?
|
| Fires | 2 | 1982 | 170 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 2007 | 4168 | 0.060 |
Why?
|
| Kidney | 3 | 2016 | 7064 | 0.060 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1986 | 430 | 0.060 |
Why?
|
| Energy Transfer | 2 | 2001 | 109 | 0.060 |
Why?
|
| Hyperuricemia | 1 | 2006 | 222 | 0.050 |
Why?
|
| Fracture Fixation, Internal | 1 | 2010 | 982 | 0.050 |
Why?
|
| Occupations | 1 | 1986 | 516 | 0.050 |
Why?
|
| Isoleucine | 1 | 2003 | 111 | 0.050 |
Why?
|
| DNA Probes | 1 | 2024 | 542 | 0.050 |
Why?
|
| Pseudomonas Infections | 1 | 2008 | 623 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 2065 | 0.050 |
Why?
|
| Blood Pressure Determination | 2 | 2003 | 646 | 0.050 |
Why?
|
| Workflow | 2 | 2020 | 860 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 6526 | 0.050 |
Why?
|
| Rivers | 1 | 2003 | 65 | 0.050 |
Why?
|
| Tars | 1 | 1983 | 20 | 0.050 |
Why?
|
| Receptor, Cholecystokinin A | 1 | 2023 | 13 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2013 | 2935 | 0.050 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2001 | 169 | 0.050 |
Why?
|
| Latin America | 1 | 2024 | 416 | 0.050 |
Why?
|
| Social Control, Formal | 1 | 1983 | 107 | 0.050 |
Why?
|
| School Health Services | 1 | 1987 | 388 | 0.050 |
Why?
|
| Tissue Distribution | 3 | 2024 | 2300 | 0.050 |
Why?
|
| Swine | 2 | 2010 | 5995 | 0.050 |
Why?
|
| Epidemiologic Studies | 2 | 2004 | 677 | 0.050 |
Why?
|
| Mental Status Schedule | 1 | 2003 | 315 | 0.050 |
Why?
|
| Durapatite | 1 | 2004 | 167 | 0.050 |
Why?
|
| Nebulizers and Vaporizers | 3 | 2008 | 139 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2013 | 5902 | 0.050 |
Why?
|
| Imipramine | 2 | 1993 | 98 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2013 | 2028 | 0.050 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2004 | 361 | 0.050 |
Why?
|
| Alprazolam | 2 | 1993 | 103 | 0.050 |
Why?
|
| Prejudice | 1 | 2007 | 574 | 0.050 |
Why?
|
| Biochemical Phenomena | 1 | 2003 | 59 | 0.050 |
Why?
|
| Adenoma | 1 | 2013 | 2159 | 0.050 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 2 | 2001 | 113 | 0.050 |
Why?
|
| Action Potentials | 1 | 2010 | 1838 | 0.050 |
Why?
|
| Axonemal Dyneins | 1 | 2022 | 25 | 0.050 |
Why?
|
| Ascariasis | 1 | 2002 | 13 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2018 | 4852 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2013 | 2982 | 0.050 |
Why?
|
| Hemochromatosis | 1 | 2004 | 175 | 0.050 |
Why?
|
| Ascaris lumbricoides | 1 | 2002 | 10 | 0.050 |
Why?
|
| Government Regulation | 1 | 2007 | 525 | 0.050 |
Why?
|
| Marijuana Abuse | 1 | 1987 | 409 | 0.050 |
Why?
|
| Substance-Related Disorders | 3 | 2007 | 4423 | 0.050 |
Why?
|
| Censuses | 1 | 2023 | 198 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2009 | 1429 | 0.050 |
Why?
|
| Blood Glucose | 5 | 2005 | 6430 | 0.050 |
Why?
|
| Cholecystokinin | 1 | 2023 | 115 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 1904 | 0.050 |
Why?
|
| Antigens, Plant | 4 | 2004 | 104 | 0.050 |
Why?
|
| Electroencephalography | 2 | 2013 | 6314 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2633 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2004 | 588 | 0.050 |
Why?
|
| Genes, Recessive | 4 | 2003 | 625 | 0.050 |
Why?
|
| K562 Cells | 1 | 2024 | 644 | 0.050 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2002 | 147 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 2015 | 2678 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 1997 | 4978 | 0.050 |
Why?
|
| Bone Substitutes | 1 | 2004 | 233 | 0.050 |
Why?
|
| Ceramides | 1 | 2023 | 203 | 0.050 |
Why?
|
| Anticholesteremic Agents | 2 | 2001 | 972 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
| Mouth | 2 | 2016 | 383 | 0.050 |
Why?
|
| Patient Selection | 1 | 2014 | 4260 | 0.050 |
Why?
|
| Infant Food | 1 | 2002 | 139 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2018 | 760 | 0.050 |
Why?
|
| Weight Gain | 2 | 2005 | 2359 | 0.050 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 344 | 0.050 |
Why?
|
| Adrenal Insufficiency | 1 | 2024 | 195 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 1987 | 998 | 0.050 |
Why?
|
| Duty to Recontact | 1 | 2021 | 19 | 0.050 |
Why?
|
| Temporal Arteries | 1 | 2023 | 155 | 0.050 |
Why?
|
| Health Behavior | 3 | 2014 | 2650 | 0.050 |
Why?
|
| Cell Communication | 1 | 2009 | 1660 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2008 | 857 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2023 | 417 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 1039 | 0.050 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2019 | 192 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5804 | 0.050 |
Why?
|
| Memory | 2 | 1998 | 2208 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2009 | 1131 | 0.050 |
Why?
|
| Pollen | 3 | 2002 | 80 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 20760 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1995 | 564 | 0.050 |
Why?
|
| Genetics | 1 | 2002 | 114 | 0.050 |
Why?
|
| Nuclear Matrix | 1 | 2001 | 30 | 0.050 |
Why?
|
| Histamine H1 Antagonists | 1 | 2002 | 101 | 0.050 |
Why?
|
| Hemodynamics | 3 | 2000 | 4194 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 5 | 2020 | 5536 | 0.050 |
Why?
|
| Glutamine | 1 | 2004 | 577 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2010 | 1673 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2008 | 4413 | 0.050 |
Why?
|
| Iceland | 1 | 2001 | 183 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 6514 | 0.050 |
Why?
|
| Administration, Intranasal | 2 | 2002 | 485 | 0.050 |
Why?
|
| Child Welfare | 2 | 2004 | 523 | 0.050 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2007 | 558 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2015 | 432 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1683 | 0.050 |
Why?
|
| Enzymes | 1 | 2003 | 254 | 0.050 |
Why?
|
| Pulmonary Diffusing Capacity | 2 | 1980 | 93 | 0.050 |
Why?
|
| Emergency Treatment | 2 | 2008 | 497 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 1681 | 0.050 |
Why?
|
| Oregon | 1 | 2001 | 149 | 0.050 |
Why?
|
| Nutrition Assessment | 1 | 2024 | 740 | 0.050 |
Why?
|
| Maximal Expiratory Flow Rate | 5 | 1987 | 42 | 0.050 |
Why?
|
| Cell Adhesion | 3 | 2015 | 3096 | 0.050 |
Why?
|
| Water Supply | 1 | 1982 | 204 | 0.050 |
Why?
|
| Social Change | 2 | 1992 | 152 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 3044 | 0.050 |
Why?
|
| Lovastatin | 1 | 2001 | 115 | 0.050 |
Why?
|
| Methionine | 1 | 2003 | 573 | 0.050 |
Why?
|
| Dyspnea | 4 | 2021 | 1352 | 0.050 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 42 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5703 | 0.050 |
Why?
|
| Parasitic Diseases | 1 | 2001 | 76 | 0.050 |
Why?
|
| Spiro Compounds | 1 | 2001 | 69 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2003 | 611 | 0.040 |
Why?
|
| Genetic Research | 1 | 2021 | 173 | 0.040 |
Why?
|
| Students | 1 | 1991 | 1744 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2014 | 3800 | 0.040 |
Why?
|
| Personality | 2 | 2002 | 559 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2021 | 187 | 0.040 |
Why?
|
| Helminthiasis, Animal | 1 | 2000 | 4 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2005 | 1880 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2022 | 304 | 0.040 |
Why?
|
| Hyperventilation | 3 | 1986 | 78 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6568 | 0.040 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 1999 | 40 | 0.040 |
Why?
|
| Sulfotransferases | 1 | 2021 | 150 | 0.040 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2000 | 308 | 0.040 |
Why?
|
| Dysostoses | 1 | 1999 | 7 | 0.040 |
Why?
|
| Biopolymers | 1 | 2001 | 183 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 465 | 0.040 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2020 | 148 | 0.040 |
Why?
|
| Fluorine Radioisotopes | 2 | 1994 | 425 | 0.040 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2000 | 97 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 267 | 0.040 |
Why?
|
| Cholagogues and Choleretics | 1 | 1999 | 39 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2010 | 4206 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 1998 | 783 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 1247 | 0.040 |
Why?
|
| Sickness Impact Profile | 1 | 2001 | 299 | 0.040 |
Why?
|
| Digestive System Diseases | 1 | 2021 | 152 | 0.040 |
Why?
|
| Interleukin-5 | 2 | 2015 | 267 | 0.040 |
Why?
|
| Poverty | 4 | 2006 | 2720 | 0.040 |
Why?
|
| Motor Activity | 2 | 2010 | 2711 | 0.040 |
Why?
|
| Functional Residual Capacity | 4 | 2010 | 70 | 0.040 |
Why?
|
| Lymphocyte Activation | 7 | 2006 | 5505 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 297 | 0.040 |
Why?
|
| Mental Health | 1 | 2014 | 3275 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2011 | 2062 | 0.040 |
Why?
|
| Aortic Aneurysm | 1 | 2024 | 649 | 0.040 |
Why?
|
| Critical Care | 2 | 2022 | 2715 | 0.040 |
Why?
|
| Panic Disorder | 2 | 1993 | 613 | 0.040 |
Why?
|
| Germany | 2 | 2014 | 883 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2020 | 197 | 0.040 |
Why?
|
| Denmark | 1 | 2021 | 776 | 0.040 |
Why?
|
| Bronchography | 1 | 1999 | 74 | 0.040 |
Why?
|
| Isoproterenol | 3 | 2008 | 398 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 2176 | 0.040 |
Why?
|
| Syndrome | 2 | 2004 | 3272 | 0.040 |
Why?
|
| Ketorolac | 1 | 1999 | 95 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2004 | 829 | 0.040 |
Why?
|
| Trisaccharides | 1 | 1998 | 50 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2019 | 100 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2020 | 2857 | 0.040 |
Why?
|
| Trachea | 2 | 1999 | 1095 | 0.040 |
Why?
|
| Diffusion | 1 | 2001 | 815 | 0.040 |
Why?
|
| Adolescent Behavior | 1 | 1987 | 1186 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 11095 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2009 | 2880 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3250 | 0.040 |
Why?
|
| Digestive System | 1 | 1999 | 244 | 0.040 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1999 | 136 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 473 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2003 | 620 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2001 | 648 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1998 | 1815 | 0.040 |
Why?
|
| Cathepsins | 1 | 1999 | 243 | 0.040 |
Why?
|
| Colestipol | 1 | 2018 | 11 | 0.040 |
Why?
|
| Cholestyramine Resin | 1 | 2018 | 25 | 0.040 |
Why?
|
| Terminology as Topic | 2 | 1999 | 1542 | 0.040 |
Why?
|
| Minority Groups | 2 | 2022 | 1216 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 2011 | 1713 | 0.040 |
Why?
|
| Nails | 1 | 2020 | 298 | 0.040 |
Why?
|
| Ileum | 1 | 2021 | 558 | 0.040 |
Why?
|
| Clostridium | 1 | 2018 | 100 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 255 | 0.040 |
Why?
|
| Fibric Acids | 1 | 2018 | 27 | 0.040 |
Why?
|
| Africa | 1 | 2020 | 725 | 0.040 |
Why?
|
| Pharmacokinetics | 2 | 2010 | 86 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2001 | 432 | 0.040 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 1999 | 115 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 353 | 0.040 |
Why?
|
| Thinness | 1 | 2001 | 483 | 0.040 |
Why?
|
| Drug Therapy, Combination | 6 | 2011 | 6316 | 0.040 |
Why?
|
| Milk, Human | 1 | 2022 | 490 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2020 | 493 | 0.040 |
Why?
|
| Personality Disorders | 1 | 2003 | 726 | 0.040 |
Why?
|
| Terbutaline | 1 | 1997 | 26 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2018 | 99 | 0.040 |
Why?
|
| Bacteroides | 1 | 2018 | 165 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2004 | 1474 | 0.040 |
Why?
|
| Adiposity | 1 | 2008 | 1895 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 836 | 0.040 |
Why?
|
| Cost of Illness | 3 | 2002 | 1951 | 0.040 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2021 | 374 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2009 | 3124 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1135 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2004 | 848 | 0.040 |
Why?
|
| Epidemiology | 1 | 1980 | 278 | 0.040 |
Why?
|
| Thorax | 1 | 1981 | 557 | 0.040 |
Why?
|
| Homeodomain Proteins | 2 | 1998 | 2429 | 0.040 |
Why?
|
| Ciliary Body | 1 | 1998 | 168 | 0.040 |
Why?
|
| Fungi | 1 | 2020 | 345 | 0.040 |
Why?
|
| Pravastatin | 1 | 2000 | 393 | 0.040 |
Why?
|
| Mosaicism | 1 | 2021 | 480 | 0.040 |
Why?
|
| Phosphorylases | 1 | 1997 | 17 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 365 | 0.040 |
Why?
|
| Epigenomics | 1 | 2023 | 960 | 0.040 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2001 | 399 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2015 | 866 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 1074 | 0.040 |
Why?
|
| Glycogen Storage Disease Type V | 1 | 1997 | 8 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1999 | 705 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2002 | 772 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 1461 | 0.040 |
Why?
|
| Brain | 4 | 2020 | 27360 | 0.040 |
Why?
|
| Meglumine | 1 | 2018 | 144 | 0.040 |
Why?
|
| Pulmonary Ventilation | 5 | 1994 | 375 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2010 | 2295 | 0.040 |
Why?
|
| Anterior Eye Segment | 1 | 1998 | 144 | 0.040 |
Why?
|
| Plant Roots | 1 | 2017 | 122 | 0.040 |
Why?
|
| Soil Microbiology | 1 | 2017 | 92 | 0.040 |
Why?
|
| Zea mays | 1 | 2017 | 109 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 1999 | 250 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2020 | 841 | 0.040 |
Why?
|
| Simvastatin | 1 | 2000 | 346 | 0.040 |
Why?
|
| STAT2 Transcription Factor | 1 | 2017 | 27 | 0.040 |
Why?
|
| Fibroma, Desmoplastic | 1 | 1996 | 6 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 2001 | 583 | 0.040 |
Why?
|
| Abdomen | 2 | 1994 | 1136 | 0.040 |
Why?
|
| Desmosine | 1 | 1996 | 19 | 0.030 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1997 | 317 | 0.030 |
Why?
|
| Neoplasms | 4 | 2020 | 22371 | 0.030 |
Why?
|
| Pregnancy Outcome | 2 | 2014 | 2972 | 0.030 |
Why?
|
| Nucleoproteins | 1 | 1997 | 110 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 1997 | 201 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2017 | 69 | 0.030 |
Why?
|
| Niacin | 1 | 1998 | 117 | 0.030 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 1998 | 94 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 2003 | 1351 | 0.030 |
Why?
|
| Infant Formula | 1 | 2018 | 194 | 0.030 |
Why?
|
| Histone Code | 1 | 2017 | 160 | 0.030 |
Why?
|
| Mice, Transgenic | 4 | 2024 | 9561 | 0.030 |
Why?
|
| Protein Folding | 1 | 2001 | 871 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1999 | 694 | 0.030 |
Why?
|
| Stroke | 1 | 2019 | 9755 | 0.030 |
Why?
|
| Amino Acids | 1 | 2023 | 1716 | 0.030 |
Why?
|
| Clonal Deletion | 1 | 1996 | 75 | 0.030 |
Why?
|
| Bacteroides fragilis | 1 | 2018 | 250 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2008 | 1885 | 0.030 |
Why?
|
| Radiopharmaceuticals | 2 | 1999 | 2735 | 0.030 |
Why?
|
| Open Reading Frames | 2 | 2012 | 818 | 0.030 |
Why?
|
| Protease Nexins | 2 | 2006 | 39 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2008 | 2401 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1997 | 383 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2008 | 1946 | 0.030 |
Why?
|
| NAD | 1 | 2020 | 618 | 0.030 |
Why?
|
| Oocytes | 1 | 2021 | 1172 | 0.030 |
Why?
|
| Testis | 1 | 2000 | 783 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2003 | 1407 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2023 | 2592 | 0.030 |
Why?
|
| Cations | 1 | 1997 | 240 | 0.030 |
Why?
|
| Ferritins | 1 | 2019 | 601 | 0.030 |
Why?
|
| Depressive Disorder | 2 | 2009 | 3721 | 0.030 |
Why?
|
| Indoles | 2 | 2002 | 1836 | 0.030 |
Why?
|
| Dopamine | 2 | 1994 | 1592 | 0.030 |
Why?
|
| Radiography, Thoracic | 2 | 2000 | 1321 | 0.030 |
Why?
|
| Energy Intake | 3 | 1992 | 2146 | 0.030 |
Why?
|
| Heptanoic Acids | 1 | 1998 | 344 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 6124 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2004 | 1702 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 229 | 0.030 |
Why?
|
| Myocardial Infarction | 6 | 1997 | 11519 | 0.030 |
Why?
|
| Self Tolerance | 1 | 1996 | 122 | 0.030 |
Why?
|
| Irritants | 1 | 1995 | 43 | 0.030 |
Why?
|
| Amines | 1 | 2017 | 280 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 69 | 0.030 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2008 | 328 | 0.030 |
Why?
|
| Ascorbic Acid Deficiency | 2 | 1998 | 26 | 0.030 |
Why?
|
| Disclosure | 1 | 2021 | 755 | 0.030 |
Why?
|
| Gastrectomy | 1 | 2021 | 693 | 0.030 |
Why?
|
| Pseudogenes | 1 | 1995 | 104 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2015 | 26 | 0.030 |
Why?
|
| Eosinophil Major Basic Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 287 | 0.030 |
Why?
|
| Collagen | 3 | 2001 | 2643 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 2000 | 906 | 0.030 |
Why?
|
| Positive-Pressure Respiration | 1 | 2000 | 713 | 0.030 |
Why?
|
| Sialic Acids | 1 | 1995 | 123 | 0.030 |
Why?
|
| Residence Characteristics | 3 | 2001 | 2118 | 0.030 |
Why?
|
| Organ Size | 1 | 2020 | 2267 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 486 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2020 | 708 | 0.030 |
Why?
|
| Acute Disease | 7 | 2006 | 7243 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 343 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2024 | 2323 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1999 | 1156 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1999 | 899 | 0.030 |
Why?
|
| Carboxyhemoglobin | 3 | 1992 | 83 | 0.030 |
Why?
|
| Hepatitis, Viral, Animal | 1 | 1995 | 10 | 0.030 |
Why?
|
| Cell Size | 1 | 2017 | 626 | 0.030 |
Why?
|
| Health Status | 1 | 2008 | 4091 | 0.030 |
Why?
|
| Radiometry | 1 | 2001 | 818 | 0.030 |
Why?
|
| Magnetoencephalography | 1 | 1999 | 641 | 0.030 |
Why?
|
| Uveal Neoplasms | 1 | 1998 | 344 | 0.030 |
Why?
|
| Mitogens | 2 | 2005 | 229 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2020 | 764 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 2002 | 836 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2017 | 246 | 0.030 |
Why?
|
| Informed Consent | 1 | 2021 | 1010 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 9419 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2009 | 3231 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2006 | 4035 | 0.030 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1995 | 175 | 0.030 |
Why?
|
| Peer Group | 2 | 2005 | 700 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 2 | 1998 | 937 | 0.030 |
Why?
|
| Apoptosis | 2 | 2009 | 9523 | 0.030 |
Why?
|
| Mexico | 2 | 2009 | 769 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2011 | 275 | 0.030 |
Why?
|
| Natural Killer T-Cells | 1 | 2018 | 318 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 1494 | 0.030 |
Why?
|
| Hearing Disorders | 1 | 1975 | 126 | 0.030 |
Why?
|
| Neurons | 3 | 2000 | 9514 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1995 | 310 | 0.030 |
Why?
|
| Inspiratory Capacity | 4 | 1999 | 35 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2000 | 714 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2021 | 1778 | 0.030 |
Why?
|
| Rhode Island | 1 | 2015 | 352 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2018 | 823 | 0.030 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1996 | 243 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2023 | 3428 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2227 | 0.030 |
Why?
|
| Y Chromosome | 1 | 1995 | 205 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1998 | 2568 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1995 | 243 | 0.030 |
Why?
|
| Depression | 2 | 2022 | 8230 | 0.030 |
Why?
|
| Magnesium Deficiency | 1 | 1994 | 48 | 0.030 |
Why?
|
| Endosomes | 1 | 1997 | 522 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2020 | 1505 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 648 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2006 | 3205 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 2232 | 0.030 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2014 | 64 | 0.030 |
Why?
|
| Papaverine | 1 | 1973 | 45 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2014 | 286 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2004 | 1893 | 0.030 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1996 | 290 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2004 | 2981 | 0.030 |
Why?
|
| Cytosol | 1 | 1997 | 887 | 0.030 |
Why?
|
| Cell Lineage | 2 | 2000 | 2575 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2000 | 1676 | 0.030 |
Why?
|
| Program Development | 1 | 2000 | 1300 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1327 | 0.030 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2015 | 199 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2016 | 591 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 13676 | 0.030 |
Why?
|
| Spouses | 1 | 1996 | 286 | 0.030 |
Why?
|
| Taste | 1 | 1995 | 190 | 0.030 |
Why?
|
| Camptothecin | 1 | 2017 | 600 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2017 | 420 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2013 | 38 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 9015 | 0.030 |
Why?
|
| Thymus Gland | 2 | 1998 | 1266 | 0.030 |
Why?
|
| Radiography | 2 | 2000 | 6983 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 6974 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 409 | 0.030 |
Why?
|
| Social Identification | 1 | 1994 | 108 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2011 | 5027 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 1994 | 333 | 0.030 |
Why?
|
| Cognition | 2 | 2003 | 7073 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 435 | 0.030 |
Why?
|
| Calcium, Dietary | 1 | 1996 | 533 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3980 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1998 | 2258 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 1760 | 0.030 |
Why?
|
| Viruses | 1 | 2017 | 373 | 0.030 |
Why?
|
| Meningitis | 1 | 1995 | 219 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 1995 | 406 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2006 | 3479 | 0.030 |
Why?
|
| Gout | 1 | 2000 | 621 | 0.030 |
Why?
|
| Cysts | 1 | 1998 | 685 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2021 | 1143 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 1997 | 995 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 2087 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2016 | 3228 | 0.030 |
Why?
|
| Health Services Accessibility | 2 | 2008 | 5520 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 1998 | 1150 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2021 | 2507 | 0.030 |
Why?
|
| Smell | 1 | 1995 | 260 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2012 | 88 | 0.030 |
Why?
|
| Gadolinium | 1 | 2018 | 964 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2018 | 864 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 2012 | 231 | 0.030 |
Why?
|
| Survival Rate | 2 | 2006 | 12840 | 0.030 |
Why?
|
| Models, Animal | 2 | 2012 | 2120 | 0.030 |
Why?
|
| Death, Sudden | 1 | 1994 | 301 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1996 | 812 | 0.030 |
Why?
|
| Alcoholic Beverages | 1 | 1994 | 266 | 0.030 |
Why?
|
| SRS-A | 1 | 1992 | 132 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2017 | 582 | 0.030 |
Why?
|
| Nutrition Surveys | 2 | 2005 | 1738 | 0.030 |
Why?
|
| Pyrenes | 1 | 2012 | 51 | 0.030 |
Why?
|
| Xanthines | 1 | 1992 | 121 | 0.030 |
Why?
|
| Cell Division | 1 | 2000 | 4473 | 0.030 |
Why?
|
| Thymidylate Synthase | 1 | 2012 | 74 | 0.030 |
Why?
|
| Fetal Organ Maturity | 1 | 1992 | 83 | 0.030 |
Why?
|
| Untranslated Regions | 1 | 2012 | 30 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2000 | 2414 | 0.020 |
Why?
|
| Sarcosine Dehydrogenase | 1 | 2011 | 5 | 0.020 |
Why?
|
| Formate-Tetrahydrofolate Ligase | 1 | 2011 | 6 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1864 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2012 | 455 | 0.020 |
Why?
|
| Matched-Pair Analysis | 2 | 2004 | 285 | 0.020 |
Why?
|
| Sp3 Transcription Factor | 1 | 2011 | 30 | 0.020 |
Why?
|
| Pregnancy, Multiple | 1 | 1993 | 216 | 0.020 |
Why?
|
| Aminohydrolases | 1 | 2011 | 18 | 0.020 |
Why?
|
| RNA Interference | 1 | 2020 | 2832 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 633 | 0.020 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2011 | 19 | 0.020 |
Why?
|
| Equipment Design | 1 | 2000 | 3522 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1993 | 137 | 0.020 |
Why?
|
| Prostatic Hyperplasia | 1 | 1996 | 516 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2003 | 2100 | 0.020 |
Why?
|
| Physical Exertion | 2 | 1993 | 668 | 0.020 |
Why?
|
| X Chromosome | 1 | 1995 | 819 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 36743 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 1995 | 736 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1998 | 997 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2015 | 809 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 742 | 0.020 |
Why?
|
| Point Mutation | 1 | 1997 | 1596 | 0.020 |
Why?
|
| Diarrhea | 1 | 2018 | 1320 | 0.020 |
Why?
|
| France | 1 | 2013 | 497 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 246 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 942 | 0.020 |
Why?
|
| Pyrroles | 1 | 1998 | 1124 | 0.020 |
Why?
|
| Water | 2 | 1998 | 1421 | 0.020 |
Why?
|
| Binding Sites | 2 | 2010 | 6020 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2469 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 757 | 0.020 |
Why?
|
| Fluconazole | 1 | 1992 | 156 | 0.020 |
Why?
|
| Hip | 1 | 1992 | 256 | 0.020 |
Why?
|
| Alu Elements | 1 | 2011 | 115 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 294 | 0.020 |
Why?
|
| Personality Inventory | 1 | 1994 | 1018 | 0.020 |
Why?
|
| Desoxycorticosterone | 1 | 1991 | 46 | 0.020 |
Why?
|
| Diabetic Neuropathies | 1 | 1975 | 410 | 0.020 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 1991 | 20 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3445 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8542 | 0.020 |
Why?
|
| Interleukins | 2 | 2008 | 796 | 0.020 |
Why?
|
| Fractures, Malunited | 1 | 2011 | 82 | 0.020 |
Why?
|
| Community Networks | 1 | 2013 | 202 | 0.020 |
Why?
|
| Gene Library | 1 | 2014 | 1064 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 1995 | 992 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 622 | 0.020 |
Why?
|
| Tubulin | 1 | 1994 | 695 | 0.020 |
Why?
|
| Caribbean Region | 1 | 2011 | 193 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2000 | 2430 | 0.020 |
Why?
|
| Encephalitis | 1 | 1995 | 441 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 1994 | 426 | 0.020 |
Why?
|
| Breast Neoplasms | 3 | 2001 | 21206 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 1998 | 1514 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2000 | 1605 | 0.020 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2010 | 56 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2001 | 2235 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 670 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2012 | 1162 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 417 | 0.020 |
Why?
|
| Paired-Associate Learning | 1 | 1990 | 54 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1991 | 292 | 0.020 |
Why?
|
| Vitamin B 6 | 1 | 2011 | 237 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1992 | 406 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1999 | 1266 | 0.020 |
Why?
|
| Pulmonary Medicine | 2 | 2006 | 223 | 0.020 |
Why?
|
| Pandemics | 2 | 2021 | 8748 | 0.020 |
Why?
|
| Veterans | 2 | 2003 | 2669 | 0.020 |
Why?
|
| Retinitis Pigmentosa | 1 | 1994 | 395 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 1839 | 0.020 |
Why?
|
| Body Burden | 2 | 2004 | 158 | 0.020 |
Why?
|
| Immunity | 1 | 2016 | 1003 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1996 | 812 | 0.020 |
Why?
|
| Androstadienes | 1 | 2012 | 348 | 0.020 |
Why?
|
| Heart Block | 2 | 1998 | 390 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1992 | 389 | 0.020 |
Why?
|
| Markov Chains | 2 | 2006 | 979 | 0.020 |
Why?
|
| Barbados | 1 | 2009 | 52 | 0.020 |
Why?
|
| Intradermal Tests | 2 | 2001 | 43 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 1992 | 381 | 0.020 |
Why?
|
| New England | 2 | 2005 | 1058 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1995 | 1528 | 0.020 |
Why?
|
| Weight Loss | 1 | 2001 | 2721 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2022 | 3706 | 0.020 |
Why?
|
| Self Care | 2 | 2006 | 799 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2009 | 93 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 905 | 0.020 |
Why?
|
| Inhalation | 1 | 2010 | 145 | 0.020 |
Why?
|
| Societies, Medical | 2 | 2018 | 3968 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 1907 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2009 | 104 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2006 | 707 | 0.020 |
Why?
|
| Anesthesia | 1 | 2000 | 1596 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 255 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2011 | 344 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 858 | 0.020 |
Why?
|
| Data Compression | 1 | 2009 | 69 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 320 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 1994 | 797 | 0.020 |
Why?
|
| Morals | 1 | 1992 | 288 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2009 | 169 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2010 | 297 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2004 | 766 | 0.020 |
Why?
|
| Mitomycins | 1 | 1988 | 46 | 0.020 |
Why?
|
| Anxiety Disorders | 2 | 1998 | 2748 | 0.020 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 2337 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2219 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1991 | 584 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 455 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2003 | 3447 | 0.020 |
Why?
|
| Carbon | 1 | 2012 | 673 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 1989 | 236 | 0.020 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1993 | 519 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 1135 | 0.020 |
Why?
|
| Autoimmunity | 1 | 1996 | 1361 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2009 | 612 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2011 | 664 | 0.020 |
Why?
|
| Pregnenediones | 1 | 1988 | 29 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 2560 | 0.020 |
Why?
|
| Echocardiography | 1 | 2021 | 5047 | 0.020 |
Why?
|
| Hemoglobins | 3 | 2010 | 1531 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 4528 | 0.020 |
Why?
|
| Spectrometry, X-Ray Emission | 2 | 2001 | 144 | 0.020 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 1993 | 843 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1996 | 1997 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2011 | 597 | 0.020 |
Why?
|
| Coffee | 1 | 1992 | 594 | 0.020 |
Why?
|
| Electronics | 1 | 2009 | 317 | 0.020 |
Why?
|
| Sex Ratio | 1 | 2008 | 107 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5315 | 0.020 |
Why?
|
| Research | 1 | 2016 | 1979 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1997 | 3655 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2009 | 278 | 0.020 |
Why?
|
| Seasons | 1 | 1993 | 1524 | 0.020 |
Why?
|
| Twins | 1 | 1989 | 341 | 0.020 |
Why?
|
| Mitomycin | 1 | 1988 | 261 | 0.020 |
Why?
|
| Viral Load | 1 | 2017 | 3396 | 0.020 |
Why?
|
| Frail Elderly | 1 | 1993 | 781 | 0.020 |
Why?
|
| Bone Plates | 1 | 2010 | 468 | 0.020 |
Why?
|
| Health | 1 | 2010 | 398 | 0.020 |
Why?
|
| Collagen Type I | 2 | 2001 | 618 | 0.020 |
Why?
|
| Models, Econometric | 1 | 2008 | 215 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 1989 | 472 | 0.020 |
Why?
|
| Registries | 2 | 2020 | 8375 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2000 | 3239 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 1997 | 1807 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1988 | 11878 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4283 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6793 | 0.020 |
Why?
|
| Dietary Fiber | 1 | 1991 | 767 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2000 | 10101 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2006 | 1741 | 0.020 |
Why?
|
| Complement C5 | 2 | 1997 | 104 | 0.020 |
Why?
|
| Vinblastine | 1 | 1988 | 487 | 0.020 |
Why?
|
| Informatics | 1 | 2007 | 72 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2010 | 300 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2010 | 1151 | 0.020 |
Why?
|
| Length of Stay | 1 | 2020 | 6498 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2013 | 1489 | 0.020 |
Why?
|
| Compliance | 1 | 2006 | 100 | 0.020 |
Why?
|
| Heart Conduction System | 2 | 1998 | 1009 | 0.020 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2006 | 40 | 0.020 |
Why?
|
| Crosses, Genetic | 2 | 1998 | 752 | 0.020 |
Why?
|
| Hydralazine | 1 | 1986 | 34 | 0.020 |
Why?
|
| Diet Surveys | 1 | 1990 | 1160 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2008 | 605 | 0.020 |
Why?
|
| Postpartum Period | 1 | 1993 | 1198 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2007 | 355 | 0.020 |
Why?
|
| Residual Volume | 2 | 1988 | 40 | 0.020 |
Why?
|
| Zinc | 1 | 1990 | 677 | 0.020 |
Why?
|
| Australia | 1 | 2009 | 1265 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2010 | 620 | 0.020 |
Why?
|
| Tropoelastin | 1 | 2005 | 28 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2012 | 1469 | 0.020 |
Why?
|
| RNA Stability | 1 | 2007 | 319 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2012 | 2089 | 0.020 |
Why?
|
| Insurance | 1 | 2007 | 115 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 31 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 1524 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2017 | 4214 | 0.020 |
Why?
|
| Polysorbates | 1 | 2005 | 46 | 0.020 |
Why?
|
| Minnesota | 1 | 1986 | 339 | 0.020 |
Why?
|
| Brain Death | 1 | 2008 | 359 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2005 | 44 | 0.020 |
Why?
|
| Clinical Medicine | 1 | 2006 | 145 | 0.020 |
Why?
|
| Administration, Topical | 2 | 2003 | 703 | 0.020 |
Why?
|
| Croup | 1 | 1985 | 23 | 0.020 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2006 | 161 | 0.020 |
Why?
|
| Quality of Health Care | 2 | 2003 | 4310 | 0.020 |
Why?
|
| Lung Neoplasms | 3 | 1987 | 13586 | 0.020 |
Why?
|
| Michigan | 1 | 1986 | 330 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2457 | 0.020 |
Why?
|
| Pain | 1 | 2000 | 5100 | 0.020 |
Why?
|
| Allergy and Immunology | 1 | 2006 | 175 | 0.020 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2006 | 199 | 0.020 |
Why?
|
| Counseling | 1 | 2013 | 1554 | 0.010 |
Why?
|
| Metered Dose Inhalers | 1 | 2004 | 28 | 0.010 |
Why?
|
| Accidental Falls | 1 | 1993 | 1080 | 0.010 |
Why?
|
| Epoxy Compounds | 1 | 2005 | 137 | 0.010 |
Why?
|
| Puberty | 1 | 2008 | 501 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 165 | 0.010 |
Why?
|
| Lipid A | 1 | 2004 | 70 | 0.010 |
Why?
|
| Desipramine | 1 | 2004 | 183 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 2004 | 165 | 0.010 |
Why?
|
| Protein Binding | 1 | 2017 | 9343 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 1798 | 0.010 |
Why?
|
| Connecticut | 1 | 2005 | 366 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 1997 | 411 | 0.010 |
Why?
|
| Treatment Refusal | 1 | 2008 | 433 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2017 | 3073 | 0.010 |
Why?
|
| Epoxide Hydrolases | 1 | 2005 | 122 | 0.010 |
Why?
|
| Eating | 1 | 1991 | 1542 | 0.010 |
Why?
|
| Income | 3 | 2000 | 1878 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1984 | 311 | 0.010 |
Why?
|
| Microtubules | 1 | 2009 | 1064 | 0.010 |
Why?
|
| Endocytosis | 1 | 2008 | 956 | 0.010 |
Why?
|
| Bronchial Fistula | 1 | 1984 | 83 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2003 | 195 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 2005 | 265 | 0.010 |
Why?
|
| Reaction Time | 1 | 1990 | 2101 | 0.010 |
Why?
|
| Diagnosis | 1 | 1964 | 156 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2008 | 1826 | 0.010 |
Why?
|
| YY1 Transcription Factor | 1 | 2003 | 60 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 587 | 0.010 |
Why?
|
| Particulate Matter | 1 | 2015 | 2617 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 1947 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 1990 | 1835 | 0.010 |
Why?
|
| Apolipoprotein E3 | 1 | 2003 | 105 | 0.010 |
Why?
|
| Sinusitis | 1 | 1992 | 997 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 781 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2006 | 921 | 0.010 |
Why?
|
| Infant Equipment | 1 | 2002 | 23 | 0.010 |
Why?
|
| Animals, Domestic | 1 | 2002 | 56 | 0.010 |
Why?
|
| Apolipoprotein E2 | 1 | 2003 | 134 | 0.010 |
Why?
|
| Public Policy | 1 | 1987 | 552 | 0.010 |
Why?
|
| Rheumatoid Nodule | 1 | 1982 | 15 | 0.010 |
Why?
|
| Myocardium | 1 | 2016 | 4788 | 0.010 |
Why?
|
| Osseointegration | 1 | 2004 | 277 | 0.010 |
Why?
|
| Urban Health | 1 | 2005 | 535 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 13421 | 0.010 |
Why?
|
| Flucytosine | 1 | 1982 | 31 | 0.010 |
Why?
|
| Fistula | 1 | 1984 | 213 | 0.010 |
Why?
|
| Neurotoxins | 1 | 2003 | 240 | 0.010 |
Why?
|
| Phenylcarbamates | 1 | 2002 | 38 | 0.010 |
Why?
|
| Selenium | 1 | 2005 | 418 | 0.010 |
Why?
|
| Skin | 1 | 2016 | 4503 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1993 | 1930 | 0.010 |
Why?
|
| Lung Abscess | 1 | 1982 | 39 | 0.010 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2005 | 332 | 0.010 |
Why?
|
| Neuropsychological Tests | 2 | 1998 | 7140 | 0.010 |
Why?
|
| Macrophages | 1 | 1997 | 5799 | 0.010 |
Why?
|
| Alternaria | 1 | 2002 | 41 | 0.010 |
Why?
|
| Hematocrit | 1 | 1983 | 623 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1988 | 1443 | 0.010 |
Why?
|
| Amphotericin B | 1 | 1982 | 143 | 0.010 |
Why?
|
| Tosyl Compounds | 1 | 2002 | 115 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 2004 | 253 | 0.010 |
Why?
|
| Aphakia, Postcataract | 1 | 1982 | 52 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 1930 | 0.010 |
Why?
|
| Isotope Labeling | 2 | 1994 | 394 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2007 | 6029 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2005 | 779 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 3814 | 0.010 |
Why?
|
| Organizational Innovation | 1 | 2004 | 540 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1991 | 3402 | 0.010 |
Why?
|
| Vision Tests | 1 | 1982 | 160 | 0.010 |
Why?
|
| Cytosine | 1 | 1982 | 213 | 0.010 |
Why?
|
| Particle Size | 1 | 2005 | 1649 | 0.010 |
Why?
|
| Fluoxetine | 1 | 2004 | 733 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2741 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 1505 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1587 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2009 | 2512 | 0.010 |
Why?
|
| Employment | 1 | 2007 | 1110 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2009 | 3781 | 0.010 |
Why?
|
| Materials Testing | 1 | 2004 | 872 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2007 | 849 | 0.010 |
Why?
|
| Health Services | 1 | 2005 | 755 | 0.010 |
Why?
|
| Diagnosis, Differential | 3 | 2008 | 13014 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2005 | 1688 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2001 | 275 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2002 | 518 | 0.010 |
Why?
|
| Total Lung Capacity | 1 | 1980 | 148 | 0.010 |
Why?
|
| Antigens | 1 | 2006 | 1442 | 0.010 |
Why?
|
| Norway | 1 | 2001 | 501 | 0.010 |
Why?
|
| Recreation | 1 | 2001 | 124 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 1993 | 2517 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 2 | 1994 | 1126 | 0.010 |
Why?
|
| Family Characteristics | 1 | 2005 | 1003 | 0.010 |
Why?
|
| Cathepsin K | 1 | 1999 | 65 | 0.010 |
Why?
|
| Naloxone | 1 | 1982 | 372 | 0.010 |
Why?
|
| Melanoma | 1 | 1998 | 5706 | 0.010 |
Why?
|
| Attention | 1 | 1990 | 2424 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 3819 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2000 | 238 | 0.010 |
Why?
|
| Candidiasis | 1 | 1982 | 367 | 0.010 |
Why?
|
| Micrognathism | 1 | 1999 | 64 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 1988 | 923 | 0.010 |
Why?
|
| Acarbose | 1 | 1998 | 10 | 0.010 |
Why?
|
| Testosterone | 2 | 2000 | 2491 | 0.010 |
Why?
|
| Therapeutic Equivalency | 1 | 1999 | 134 | 0.010 |
Why?
|
| Adipocytes | 1 | 2006 | 1197 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2004 | 969 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2003 | 750 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1999 | 111 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 1995 | 2521 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2000 | 284 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2003 | 712 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2008 | 2381 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 2784 | 0.010 |
Why?
|
| Vehicle Emissions | 1 | 1983 | 651 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 611 | 0.010 |
Why?
|
| Helium | 2 | 1990 | 119 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2004 | 1336 | 0.010 |
Why?
|
| Growth | 1 | 2000 | 366 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 2000 | 260 | 0.010 |
Why?
|
| Transcription Factor Brn-3C | 1 | 1998 | 12 | 0.010 |
Why?
|
| Aerosols | 2 | 1993 | 634 | 0.010 |
Why?
|
| Labor, Obstetric | 1 | 1981 | 323 | 0.010 |
Why?
|
| Spleen | 1 | 2004 | 2295 | 0.010 |
Why?
|
| Sulfur Dioxide | 1 | 1998 | 178 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 2107 | 0.010 |
Why?
|
| Leptin | 1 | 2006 | 1599 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1998 | 318 | 0.010 |
Why?
|
| Medical Record Linkage | 1 | 1999 | 286 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 17140 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1997 | 72 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2000 | 336 | 0.010 |
Why?
|
| Surface Properties | 1 | 1980 | 1166 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 1997 | 245 | 0.010 |
Why?
|
| Hip Fractures | 1 | 2006 | 997 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2004 | 1377 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2004 | 1288 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 8317 | 0.010 |
Why?
|
| Vocabulary | 1 | 1998 | 167 | 0.010 |
Why?
|
| Otitis Media | 1 | 1999 | 288 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1980 | 772 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 657 | 0.010 |
Why?
|
| Phosphates | 1 | 2000 | 765 | 0.010 |
Why?
|
| Urea | 1 | 1999 | 448 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1667 | 0.010 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 1997 | 102 | 0.010 |
Why?
|
| Postprandial Period | 1 | 1998 | 320 | 0.010 |
Why?
|
| Social Conditions | 1 | 1997 | 121 | 0.010 |
Why?
|
| Health Services Research | 1 | 2004 | 1815 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1996 | 80 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1980 | 506 | 0.010 |
Why?
|
| Body Temperature | 1 | 1999 | 780 | 0.010 |
Why?
|
| Decision Making | 1 | 1990 | 3953 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1998 | 794 | 0.010 |
Why?
|
| Receptors, Interleukin-9 | 1 | 1995 | 4 | 0.010 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1995 | 20 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 2001 | 651 | 0.010 |
Why?
|
| Prednisone | 1 | 2000 | 1567 | 0.010 |
Why?
|
| Cataract | 1 | 1982 | 837 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2000 | 632 | 0.010 |
Why?
|
| Life Change Events | 1 | 2001 | 960 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1984 | 1946 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 8759 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 1982 | 1997 | 0.010 |
Why?
|
| Hair Cells, Auditory | 1 | 1998 | 382 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1995 | 142 | 0.010 |
Why?
|
| Photons | 1 | 1999 | 594 | 0.010 |
Why?
|
| Chronobiology Phenomena | 1 | 1995 | 29 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1995 | 421 | 0.010 |
Why?
|
| Retirement | 1 | 1996 | 198 | 0.010 |
Why?
|
| Vestibulocochlear Nerve | 1 | 1975 | 115 | 0.010 |
Why?
|
| Parasympathetic Nervous System | 1 | 1995 | 144 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1998 | 1216 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2007 | 2763 | 0.010 |
Why?
|
| Middle East | 1 | 1995 | 233 | 0.010 |
Why?
|
| Albuminuria | 1 | 1998 | 658 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 775 | 0.010 |
Why?
|
| Giant Cells | 1 | 1995 | 187 | 0.010 |
Why?
|
| Audiometry | 1 | 1975 | 253 | 0.010 |
Why?
|
| Life Style | 1 | 2006 | 3932 | 0.010 |
Why?
|
| Social Behavior | 1 | 2001 | 1147 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1995 | 341 | 0.010 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 1973 | 116 | 0.010 |
Why?
|
| Long QT Syndrome | 1 | 1998 | 472 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1973 | 248 | 0.010 |
Why?
|
| Pulse | 1 | 1973 | 218 | 0.010 |
Why?
|
| Spinal Fractures | 1 | 2000 | 710 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1997 | 960 | 0.010 |
Why?
|
| Rodentia | 1 | 1995 | 262 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 11101 | 0.010 |
Why?
|
| New York City | 1 | 1995 | 737 | 0.010 |
Why?
|
| Estradiol | 1 | 2000 | 1951 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1995 | 609 | 0.010 |
Why?
|
| Bacterial Typing Techniques | 1 | 1993 | 263 | 0.010 |
Why?
|
| Remission Induction | 1 | 1999 | 2410 | 0.010 |
Why?
|
| Switzerland | 1 | 1993 | 323 | 0.010 |
Why?
|
| Speech | 1 | 1998 | 557 | 0.010 |
Why?
|
| Agoraphobia | 1 | 1993 | 177 | 0.010 |
Why?
|
| Neuroimmunomodulation | 1 | 1995 | 187 | 0.010 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 1994 | 252 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1973 | 384 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2004 | 2913 | 0.010 |
Why?
|
| Vitamin A | 1 | 1995 | 611 | 0.010 |
Why?
|
| Consanguinity | 1 | 1994 | 460 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 1998 | 826 | 0.010 |
Why?
|
| Caregivers | 1 | 2004 | 2302 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1973 | 1377 | 0.010 |
Why?
|
| Morbidity | 1 | 1997 | 1755 | 0.010 |
Why?
|
| Adenine | 1 | 1997 | 995 | 0.010 |
Why?
|
| Curriculum | 1 | 1985 | 3782 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2001 | 2008 | 0.010 |
Why?
|
| Brachytherapy | 1 | 1998 | 1220 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 1993 | 411 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1744 | 0.010 |
Why?
|
| Nurses | 1 | 1999 | 2501 | 0.010 |
Why?
|
| Developing Countries | 1 | 2002 | 2910 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1998 | 1892 | 0.010 |
Why?
|
| Medically Uninsured | 1 | 1995 | 840 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 3721 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 1990 | 404 | 0.000 |
Why?
|
| Neuroglia | 1 | 1994 | 960 | 0.000 |
Why?
|
| DNA, Bacterial | 1 | 1993 | 1478 | 0.000 |
Why?
|
| Education, Medical | 1 | 1980 | 1742 | 0.000 |
Why?
|
| Maximal Expiratory Flow-Volume Curves | 1 | 1987 | 25 | 0.000 |
Why?
|
| Diabetes Complications | 1 | 1975 | 1320 | 0.000 |
Why?
|
| Child, Hospitalized | 1 | 1989 | 182 | 0.000 |
Why?
|
| Arizona | 1 | 1987 | 108 | 0.000 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1993 | 628 | 0.000 |
Why?
|
| Dietary Carbohydrates | 1 | 1992 | 896 | 0.000 |
Why?
|
| Methods | 1 | 1987 | 1066 | 0.000 |
Why?
|
| Dietary Proteins | 1 | 1992 | 960 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1994 | 2363 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1998 | 2479 | 0.000 |
Why?
|
| Sleep | 1 | 2002 | 4819 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1999 | 8741 | 0.000 |
Why?
|
| Bacteriophage lambda | 1 | 1986 | 142 | 0.000 |
Why?
|
| Atrial Fibrillation | 1 | 1964 | 5176 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1986 | 455 | 0.000 |
Why?
|
| Rabbits | 1 | 1992 | 4772 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1996 | 4912 | 0.000 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1994 | 2055 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1998 | 6004 | 0.000 |
Why?
|
| Hybridomas | 1 | 1986 | 444 | 0.000 |
Why?
|
| Histocompatibility Antigens | 1 | 1986 | 479 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1965 | 400 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1986 | 1305 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1999 | 6685 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 11244 | 0.000 |
Why?
|
| Brugada Syndrome | 1 | 1964 | 98 | 0.000 |
Why?
|
| Endorphins | 1 | 1982 | 73 | 0.000 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 1982 | 86 | 0.000 |
Why?
|
| Insurance, Health | 1 | 1995 | 2517 | 0.000 |
Why?
|
| Oxygen | 2 | 1987 | 4270 | 0.000 |
Why?
|
| Clone Cells | 1 | 1986 | 1670 | 0.000 |
Why?
|
| Physicians | 1 | 1980 | 4598 | 0.000 |
Why?
|
| Premedication | 1 | 1982 | 246 | 0.000 |
Why?
|
| Exercise Test | 1 | 1989 | 2186 | 0.000 |
Why?
|
| Health Promotion | 1 | 1993 | 2210 | 0.000 |
Why?
|
| Pharyngitis | 1 | 1982 | 222 | 0.000 |
Why?
|
| Eyeglasses | 1 | 1982 | 138 | 0.000 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 1980 | 21 | 0.000 |
Why?
|
| Lenses, Intraocular | 1 | 1982 | 141 | 0.000 |
Why?
|
| Hair | 1 | 1983 | 508 | 0.000 |
Why?
|
| Nucleotides, Cyclic | 1 | 1980 | 83 | 0.000 |
Why?
|
| Prostaglandins | 1 | 1980 | 398 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1986 | 1801 | 0.000 |
Why?
|
| Exercise | 1 | 1993 | 5955 | 0.000 |
Why?
|
| Progesterone | 1 | 1980 | 752 | 0.000 |
Why?
|
| Sarcoidosis | 1 | 1980 | 535 | 0.000 |
Why?
|
| Estrogens | 1 | 1980 | 1536 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1982 | 2714 | 0.000 |
Why?
|
| Iron Isotopes | 1 | 1965 | 19 | 0.000 |
Why?
|
| Pulmonary Embolism | 1 | 1980 | 2599 | 0.000 |
Why?
|